Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
18000,18000,,,1103701,[],CHEMBL810324,In vitro antibacterial activity against gram-positive Staphylococcus aureus 1775,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
18001,18001,,,1103702,[],CHEMBL679461,In vitro antibacterial activity against gram-positive Enterococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.39
18002,18002,,,1103703,[],CHEMBL814808,In vitro antibacterial activity against gram positive Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.78
18003,18003,,,1103704,[],CHEMBL674443,In vitro antibacterial activity against gram negative Escherichia coli KNK 437,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
18004,18004,,,1103705,[],CHEMBL764213,In vitro antibacterial activity against gram negative Pseudomonas cepacia 2961,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,6.2
18005,18005,,,1103706,[],CHEMBL760900,Not Plasmodium species,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
18006,18006,,,1103707,[],CHEMBL760898,In vitro antibacterial activity against gram negative P. aeruginosa DPHP 5263,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257449,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
18007,18007,,,1103708,[],CHEMBL734509,In vivo efficacy against Staphylococcus aureus NCTC 10649M in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,3.6
18008,18008,,,1103709,[],CHEMBL734506,In vivo efficacy against Staphylococcus aureus NCTC 10649M in mouse protection test after administration by oral gavage,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,25.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,25.0
18009,18009,,,1103710,[],CHEMBL734512,In vivo efficacy against Streptococcus pneumoniae ATCC 6303 in mouse protection test after subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,37.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,37.4
18010,18010,,,1103711,[],CHEMBL734511,In vivo efficacy against Streptococcus pneumoniae ATCC 6303 in mouse protection test after administration by oral gavage,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,100.0
18011,18011,,,1103712,[],CHEMBL736894,In vivo efficacy against Escherichia coli JUHL in mouse protection test after subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.2
18012,18012,,,1103713,[],CHEMBL736889,In vivo efficacy against Escherichia coli JUHL in mouse protection test after p.o. administration.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,1.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,1.3
18013,18013,,,1103714,[],CHEMBL734501,In vivo efficacy against Pseudomonas aeruginosa 5007 in mouse protection test after subcutaneous administration,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,2.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,2.4
18014,18014,,,1103715,[],CHEMBL736896,In vivo efficacy against Pseudomonas aeruginosa 5007 in mouse protection test after administration by oral gavage,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1132437,J Med Chem,1999.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,257449,=,1,1,=,,ED50,mg.kg-1,,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,20.0
18015,18015,,,1104004,[],CHEMBL802193,In vitro minimum inhibitory concentration (MIC) against Staphylococcus aureus Smith A 9537 at 37 degrees C for 18 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
18016,18016,,,1104005,[],CHEMBL674335,In vitro minimum inhibitory concentration (MIC) against Enterococcus faecalis A 9808 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18017,18017,,,1104006,[],CHEMBL675654,In vitro minimum inhibitory concentration (MIC) against Enterococcus faecium A 24885 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
18018,18018,,,1104007,[],CHEMBL674474,In vitro minimum inhibitory concentration (MIC) against Escherichia coli A 15119 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18019,18019,,,1104008,[],CHEMBL703679,In vitro minimum inhibitory concentration (MIC) against Klebsiella pneumoniae A 9664 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
18020,18020,,,1104009,[],CHEMBL857931,In vitro minimum inhibitory concentration (MIC) against Enterobacter cloacae A 9656 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
18021,18021,,,1104010,[],CHEMBL732722,In vitro minimum inhibitory concentration (MIC) against Morganella morganii A 15153 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
18022,18022,,,1104011,[],CHEMBL803357,In vitro minimum inhibitory concentration (MIC) against Serratia marcescens A 20019 at 37 degrees C for 18 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.3
18023,18023,,,1104012,[],CHEMBL755256,In vitro minimum inhibitory concentration (MIC) against Pseudomonas aeruginosa A 9843 at 37 degree C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.13
18024,18024,,,1104013,[],CHEMBL795173,Efficacy on systematic infections against Staphylococcus aureus Smith A 9537 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,0,=,,PD50,mg kg-1,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,3.4
18025,18025,,,1104014,[],CHEMBL755261,Efficacy on systematic infections against Pseudomonas aeruginosa A 9843 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,0,=,,PD50,mg kg-1,,2.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,2.6
18026,18026,,,1104015,[],CHEMBL676458,Efficacy on systematic infections against Escherichia coli A 15119 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.0
18027,18027,,,1104016,[],CHEMBL701270,Efficacy on systematic infections against Klebsiella pneumoniae A 9664 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,0,=,,PD50,mg kg-1,,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,PD50,mg kg-1,UO_0000308,,1.5
18028,18028,,,1104017,[],CHEMBL739717,Dose to protect 50% of mice from lethal infection after intravenous administration,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,1,=,,LD50,mg.kg-1,,273.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,273.0
18029,18029,,,1104018,[],CHEMBL740323,Dose to protect 50% of mice from lethal infection after peroral administration.,A,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,40172,=,1,1,=,,LD50,mg.kg-1,,5000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,5000.0
18030,18030,,,1104019,[],CHEMBL639390,Tested for aqueous solubility,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,1,=,,Solubility,ug.mL-1,,70.0,CHEMBL2362975,,No relevant target,,,,S,mg ml-1,UO_0000274,,0.07
18031,18031,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1104020,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL625310,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,40172,=,1,1,=,,Cmax,nM,,9053.87,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Cmax,ug ml-1,UO_0000065,,3.0
18032,18032,,,1104021,[],CHEMBL632688,Half-life time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,40172,=,1,1,=,,T1/2,hr,,3.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,T1/2,hr,UO_0000032,,3.5
18033,18033,,,1104022,[],CHEMBL621087,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40172,=,1,0,=,,AUC,ug ml-1,,20.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,ug ml-1,UO_0000274,,20.0
18034,18034,,,1104023,[],CHEMBL638292,"Percent of dose administarted, for urinary recovery determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg)",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,40172,=,1,0,=,,UR,%,,17.0,CHEMBL612558,,ADMET,,,,UR,%,UO_0000187,,17.0
18035,18035,,,1107072,[],CHEMBL673134,The compound was tested for its antibacterial activity against Enterococcus faecalis (10 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
18036,18036,,,1107073,[],CHEMBL806955,The compound was tested for its antibacterial activity against Staphylococcus aureus (12 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
18037,18037,,,1107074,[],CHEMBL806956,"The compound was tested for its antibacterial activity against Staphylococcus aureus, ciprofloxacin resistant (14 strains)",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
18038,18038,,,1107075,[],CHEMBL812368,The compound was tested for its antibacterial activity against Streptococcus pyogenes (10 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
18039,18039,,,1107076,[],CHEMBL810018,"The compound was tested for its antibacterial activity against Streptococcus pneumoniae (10 strains), expressed as MIC90",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
18040,18040,,,1107077,[],CHEMBL678658,The compound was tested for its antibacterial activity against Escherichia coli (21 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.03
18041,18041,,,1107078,[],CHEMBL689744,The compound was tested for its antibacterial activity against Haemophilus influenzae (10 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
18042,18042,,,1107079,[],CHEMBL770160,The compound was tested for its antibacterial activity against Pseudomonas aeruginosa (20 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,2.0
18043,18043,,,1107080,[],CHEMBL651786,The compound was tested for its antibacterial activity against Bacteroides fragilis (12 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152103,Bioorg Med Chem Lett,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313282,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,8.0
18044,18044,,,1115030,[],CHEMBL813961,In vitro antibacterial activity against the Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.125
18045,18045,,,1115031,[],CHEMBL813962,In vitro antibacterial activity against the Streptococcus pyogenes 77A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.391
18046,18046,,,1115032,[],CHEMBL811377,In vitro antibacterial activity against the Staphylococcus aureus SG511,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
18047,18047,,,1115033,[],CHEMBL883627,In vitro antibacterial activity against the Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.781
18048,18048,,,1115034,[],CHEMBL676273,In vitro antibacterial activity against the Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
18049,18049,,,1115035,[],CHEMBL878407,In vitro antibacterial activity against the Escherichia coli DC 2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.098
18050,18050,,,1115036,[],CHEMBL771129,In vitro antibacterial activity against the Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
18051,18051,,,1115037,[],CHEMBL771130,In vitro antibacterial activity against the Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.098
18052,18052,,,1115038,[],CHEMBL801689,In vitro antibacterial activity against the Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.013
18053,18053,,,1115039,[],CHEMBL675788,In vitro antibacterial activity against the Enterobacter cloacae 1321 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,<,1,1,<,,MIC,ug.mL-1,,0.002,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.002
18054,18054,,,1115040,[],CHEMBL808683,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 690 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
18055,18055,,,1115041,[],CHEMBL808684,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 692 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
18056,18056,,,1115042,[],CHEMBL808685,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 697 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
18057,18057,,,1115043,[],CHEMBL808686,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 701 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
18058,18058,,,1115044,[],CHEMBL808687,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 705 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.391
18059,18059,,,1115045,[],CHEMBL808688,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 707 E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
18060,18060,,,1115046,[],CHEMBL808673,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 179,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
18061,18061,,,1115047,[],CHEMBL808681,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 293,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
18062,18062,,,1115048,[],CHEMBL808682,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 303,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
18063,18063,,,1115049,[],CHEMBL804392,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus epidermidis 291,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,50.0
18064,18064,,,1115050,[],CHEMBL804394,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus epidermidis 319,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,100.0
18065,18065,,,1115051,[],CHEMBL674294,In vitro antibacterial activity against the Ofloxacin Resistant Enterococcus knothe 101,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC,ug ml-1,UO_0000274,,0.781
18066,18066,,,1115052,[],CHEMBL764222,In vitro antibacterial activity against the Ofloxacin Resistant Pseudomonas aeruginosa 279II,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.25
18067,18067,,,1115053,[],CHEMBL704917,In vitro antibacterial activity against the Ofloxacin Resistant Klebsiella species 30-92,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,MIC,ug.mL-1,,1.563,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,1.563
18068,18068,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1115054,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}]",CHEMBL622923,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,32044,=,1,1,=,,Cmax,nM,,13248.83,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,4.39
18069,18069,,,1115055,[],CHEMBL622462,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,32044,=,1,1,=,,Tmax,hr,,0.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T max,hr,UO_0000032,,0.5
18070,18070,,,1115056,[],CHEMBL620483,Half-life period for the compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,32044,=,1,1,=,,T1/2,hr,,2.07,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,hr,UO_0000032,,2.07
18071,18071,,,1115057,[],CHEMBL622024,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,32044,=,1,1,=,,AUC,ng.hr.mL-1,,12720.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug hr ml-1,,,12.72
18072,18072,,,1115058,[],CHEMBL820949,Cytotoxicity was determined for the compound in V79-4 cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,IC50,ug.mL-1,,58.55,CHEMBL612801,Cricetulus griseus,V79-4,10029.0,,,IC50,ug ml-1,UO_0000274,,58.55
18073,18073,,,1115059,[],CHEMBL693800,Cytotoxicity was determined for the compound in HepG2 cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32044,=,1,1,=,,IC50,ug.mL-1,,37.47,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,ug ml-1,UO_0000274,,37.47000000000001
18074,18074,,,1138363,[],CHEMBL651199,In vitro antibacterial activity of compound was measured against gram positive Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,mg l-1,UO_0000274,,0.03
18075,18075,,,1138364,[],CHEMBL810310,In vitro antibacterial activity of compound was measured against gram positive Staphylococcus aureus SMITH,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg l-1,UO_0000274,,0.12
18076,18076,,,1138365,[],CHEMBL810309,In vitro antibacterial activity of compound was measured against gram positive Staphylococcus aureus 1110 pen.rez.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg l-1,UO_0000274,,0.25
18077,18077,,,1138366,[],CHEMBL813997,In vitro antibacterial activity of compound was measured against gram positive Streptococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg l-1,UO_0000274,,1.0
18078,18078,,,1138367,[],CHEMBL808414,In vitro antibacterial activity of compound was measured against gram positive Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg l-1,UO_0000274,,1.0
18079,18079,,,1138368,[],CHEMBL811016,In vitro antibacterial activity of compound was measured against gram positive Streptococcus pyogenes A 118,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg l-1,UO_0000274,,1.0
18080,18080,,,1138369,[],CHEMBL811015,In vitro antibacterial activity of compound was measured against gram positive Streptococcus pyogenes A 115 ROBB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg l-1,UO_0000274,,1.0
18081,18081,,,1138370,[],CHEMBL751181,In vitro antibacterial activity of compound was measured against gram positive Mycobacterium tuberculosis H37Rv (human),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg l-1,UO_0000274,,0.2
18082,18082,,,1138371,[],CHEMBL858008,In vitro antibacterial activity of compound was measured against gram positive Mycobacterium tuberculosis Ravenel(bovin),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg l-1,UO_0000274,,0.05
18083,18083,,,1138372,[],CHEMBL859338,In vitro antibacterial activity of compound was measured against gram negative Bordetella bronchiseptica ATCC 4617,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612286,Bordetella bronchiseptica,Bordetella bronchiseptica,518.0,,,MIC,mg l-1,UO_0000274,,0.25
18084,18084,,,1138373,[],CHEMBL680455,In vitro antibacterial activity of compound was measured against gram negative Escherichia coli K12,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg l-1,UO_0000274,,0.008
18085,18085,,,1138374,[],CHEMBL680454,In vitro antibacterial activity of compound was measured against gram negative Escherichia coli 6R,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg l-1,UO_0000274,,0.12
18086,18086,,,1138375,[],CHEMBL703004,In vitro antibacterial activity of compound was measured against gram negative Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg l-1,UO_0000274,,0.008
18087,18087,,,1138376,[],CHEMBL767772,In vitro antibacterial activity of compound was measured against gram negative Proteus vulgaris XL,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,mg l-1,UO_0000274,,0.008
18088,18088,,,1138377,[],CHEMBL857316,In vitro antibacterial activity of compound was measured against gram negative Pseudomonas pyocyanea NCTC 10490,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg l-1,UO_0000274,,0.5
18089,18089,,,1138378,[],CHEMBL798166,In vitro antibacterial activity of compound was measured against gram negative Salmonella Typhimurium 51,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,mg l-1,UO_0000274,,0.015
18090,18090,,,1138379,[],CHEMBL802314,In vitro antibacterial activity of compound was measured against gram negative Shigella sonnei,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,mg l-1,UO_0000274,,0.015
18091,18091,,,1138380,[],CHEMBL659026,In vitro antibacterial activity of compound was measured against gram positive Clostridium perfringens 70500,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,mg l-1,UO_0000274,,0.4
18092,18092,,,1138381,[],CHEMBL645111,In vitro antibacterial activity of compound was measured against gram negative Acinetobacter anitratus 150001,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612453,Acinetobacter calcoaceticus subsp. anitratus,Acinetobacter calcoaceticus subsp. anitratus,107673.0,,,MIC,mg l-1,UO_0000274,,0.25
18093,18093,,,1138382,[],CHEMBL645228,In vitro antibacterial activity of compound was measured against gram negative Alcaligenes faecalis 140001,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614433,Alcaligenes faecalis,Alcaligenes faecalis,511.0,,,MIC,mg l-1,UO_0000274,,1.0
18094,18094,,,1138383,[],CHEMBL768132,In vitro antibacterial activity of compound was measured against gram negative Proteus inconstans NCTC 8055,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612338,Proteus inconstans,Proteus inconstans,84631.0,,,MIC,mg l-1,UO_0000274,,0.03
18095,18095,,,1138384,[],CHEMBL802084,In vitro antibacterial activity of compound was measured against gram negative Serratia marcescens,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg l-1,UO_0000274,,0.03
18096,18096,,,1138385,[],CHEMBL648896,In vitro antibacterial activity of compound was measured against gram negative Bacteroides fragilis ATCC 25285,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129105,Bioorg Med Chem Lett,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58403,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,mg l-1,UO_0000274,,6.2
18097,18097,,,1154274,[],CHEMBL679742,Minimum inhibitory concentration (MIC) against gram negative bacteria Enterobacter cloacae MA-2646.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
18098,18098,,,1154275,[],CHEMBL677147,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli Vogel.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
18099,18099,,,1154276,[],CHEMBL704959,Minimum inhibitory concentration (MIC) against gram negative bacteria Klebsiella pneumoniae MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
18100,18100,,,1154277,[],CHEMBL765170,Minimum inhibitory concentration (MIC) against gram negative bacteria Prot. rettgeri M-1771.,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.1
18101,18101,,,1154278,[],CHEMBL769275,Minimum inhibitory concentration (MIC) against gram negative bacteria Pseudomonas aeruginosa UI-18.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
18102,18102,,,1154279,[],CHEMBL677146,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli H-560.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
18103,18103,,,1154280,[],CHEMBL804896,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus H-228.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
18104,18104,,,1154281,[],CHEMBL804897,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
18105,18105,,,1154282,[],CHEMBL809011,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus faecalis MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
18106,18106,,,1154283,[],CHEMBL809012,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pneumoniae SV-1.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.8
18107,18107,,,1154284,[],CHEMBL809013,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pyogenes C-203.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231130,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
18108,18108,,,1154285,[],CHEMBL672335,In vivo efficacy in mouse protection test in Escherichia coli Vogel dose administered orally by gavage.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.2
18109,18109,,,1154286,[],CHEMBL672334,In vivo efficacy in mouse protection test in Escherichia coli Vogel administered by subcutaneous injection.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.25
18110,18110,,,1154287,[],CHEMBL804730,In vivo efficacy (orally) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,180.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,180.0
18111,18111,,,1154288,[],CHEMBL804729,In vivo efficacy (s.c.) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,19.0
18112,18112,,,1154289,[],CHEMBL809846,In vivo efficacy (orally) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,260.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,260.0
18113,18113,,,1154290,[],CHEMBL809845,In vivo efficacy (s.c.) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,29.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,29.0
18114,18114,,,1154291,[],CHEMBL769274,In vivo efficacy (orally) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,25.0
18115,18115,,,1154292,[],CHEMBL769273,In vivo efficacy (s.c.) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,5.0
18116,18116,,,1154293,[],CHEMBL739992,Maximum tolerance dose was measured for phototoxic skin reaction by po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,MTD,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg kg-1,UO_0000308,,300.0
18117,18117,,,1154294,[],CHEMBL663666,Number of mice which show positive phototoxic reaction in 5 mice at peroral dose,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,No. of pos rxns,,,0.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,0.0
18118,18118,,,1154295,[],CHEMBL663667,Number of mice which show positive phototoxic reaction in 5 mice at subcutaneous dose,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,No. of pos rxns,,,5.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,5.0
18119,18119,,,1154296,[],CHEMBL722856,Dose required to induce phototoxic reaction in 50% of mice by probit method at different dosage forms.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,>,1,0,>,,PTD50,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg kg-1,UO_0000308,,300.0
18120,18120,,,1154297,[],CHEMBL727080,Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,No effect dose,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg kg-1,UO_0000308,,300.0
18121,18121,,,1154298,[],CHEMBL723208,Maximum tolerance dose was measured for phototoxic skin reaction by sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,MTD,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg kg-1,UO_0000308,,100.0
18122,18122,,,1154299,[],CHEMBL734889,Days of the first positive reaction in depleted mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,Day of first positve reaction,,,2.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Day of first positve reaction,,,,2.0
18123,18123,,,1154300,[],CHEMBL722855,Dose required to induce phototoxic reaction in 50% of mice by prolit reactions at different dosage forms after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,PTD50,mg kg-1,,172.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg kg-1,UO_0000308,,172.0
18124,18124,,,1154301,[],CHEMBL727081,Compound's dose which has no effect to induce phototoxic reaction in 50% of mice by prolit reactions after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231130,=,1,0,=,,No effect dose,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg kg-1,UO_0000308,,100.0
18125,18125,,,1154302,[],CHEMBL679742,Minimum inhibitory concentration (MIC) against gram negative bacteria Enterobacter cloacae MA-2646.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
18126,18126,,,1154303,[],CHEMBL677147,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli Vogel.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
18127,18127,,,1154304,[],CHEMBL704959,Minimum inhibitory concentration (MIC) against gram negative bacteria Klebsiella pneumoniae MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
18128,18128,,,1154305,[],CHEMBL765170,Minimum inhibitory concentration (MIC) against gram negative bacteria Prot. rettgeri M-1771.,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.1
18129,18129,,,1154306,[],CHEMBL769275,Minimum inhibitory concentration (MIC) against gram negative bacteria Pseudomonas aeruginosa UI-18.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
18130,18130,,,1154307,[],CHEMBL677146,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli H-560.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
18131,18131,,,1154308,[],CHEMBL804896,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus H-228.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
18132,18132,,,1154309,[],CHEMBL804897,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
18133,18133,,,1154310,[],CHEMBL809011,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus faecalis MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
18134,18134,,,1154311,[],CHEMBL809012,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pneumoniae SV-1.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.8
18135,18135,,,1154312,[],CHEMBL809013,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pyogenes C-203.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231125,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
18136,18136,,,1154313,[],CHEMBL672335,In vivo efficacy in mouse protection test in Escherichia coli Vogel dose administered orally by gavage.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.2
18137,18137,,,1154314,[],CHEMBL672334,In vivo efficacy in mouse protection test in Escherichia coli Vogel administered by subcutaneous injection.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.25
18138,18138,,,1154315,[],CHEMBL804730,In vivo efficacy (orally) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,180.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,180.0
18139,18139,,,1154316,[],CHEMBL804729,In vivo efficacy (s.c.) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,19.0
18140,18140,,,1154317,[],CHEMBL809846,In vivo efficacy (orally) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,260.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,260.0
18141,18141,,,1154318,[],CHEMBL809845,In vivo efficacy (s.c.) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,29.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,29.0
18142,18142,,,1154319,[],CHEMBL769274,In vivo efficacy (orally) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,25.0
18143,18143,,,1154320,[],CHEMBL769273,In vivo efficacy (s.c.) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,5.0
18144,18144,,,1154321,[],CHEMBL739992,Maximum tolerance dose was measured for phototoxic skin reaction by po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,MTD,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg kg-1,UO_0000308,,300.0
18145,18145,,,1154322,[],CHEMBL739994,Maximum tolerance dose was measured for phototoxic skin reaction by sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,MTD,,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,,,,100.0
18146,18146,,,1154323,[],CHEMBL663666,Number of mice which show positive phototoxic reaction in 5 mice at peroral dose,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,No. of pos rxns,,,0.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,0.0
18147,18147,,,1154324,[],CHEMBL663667,Number of mice which show positive phototoxic reaction in 5 mice at subcutaneous dose,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,No. of pos rxns,,,5.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,5.0
18148,18148,,,1154325,[],CHEMBL663663,Days of the first positive reaction in depleted mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,Day of first positve reaction,,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Day of first positve reaction,,,,0.0
18149,18149,,,1154326,[],CHEMBL663663,Days of the first positive reaction in depleted mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,Day of first positve reaction,,,2.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Day of first positve reaction,,,,2.0
18150,18150,,,1154327,[],CHEMBL722856,Dose required to induce phototoxic reaction in 50% of mice by probit method at different dosage forms.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,>,1,0,>,,PTD50,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg kg-1,UO_0000308,,300.0
18151,18151,,,1154328,[],CHEMBL722856,Dose required to induce phototoxic reaction in 50% of mice by probit method at different dosage forms.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,PTD50,,,172.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,,,,172.0
18152,18152,,,1154329,[],CHEMBL727080,Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,No effect dose,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg kg-1,UO_0000308,,300.0
18153,18153,,,1154330,[],CHEMBL727080,Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,231125,=,1,0,=,,No effect dose,,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,,,,100.0
18154,18154,,,1154886,[],CHEMBL679918,Activity against Enterobacter aerogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,166621,=,1,0,=,,CMI,mg l-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,CMI,mg l-1,,,0.03
18155,18155,,,1154887,[],CHEMBL876624,Bioavailability,A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,166621,=,1,1,=,,F,%,,65.6,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,65.6
18156,18156,,,1173710,[],CHEMBL676794,Minimum inhibitory concentration against gram-negative Escherichia coli Vogel (EC-1),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
18157,18157,,,1173711,[],CHEMBL765862,Minimum inhibitory concentration against gram-negative Pseudomonas aeruginosa U1-18 (PA-7),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
18158,18158,,,1173712,[],CHEMBL806737,Minimum inhibitory concentration against gram-positive Staphylococcus aureus H-228 (SA-13),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
18159,18159,,,1173713,[],CHEMBL809194,Minimum inhibitory concentration against gram-positive Streptococcus pyogenes C203 (SP1-1),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
18160,18160,,,1173714,[],CHEMBL858160,Minimum inhibitory concentration against Mycobacterium fortuitum,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,0.06
18161,18161,,,1173715,[],CHEMBL751355,Minimum inhibitory concentration against Mycobacterium smegmatis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,187878,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.25
18162,18162,,,1173716,[],CHEMBL633532,Dissociation constant (pKa1),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,187878,=,1,0,=,,pKa1,,,6.19,CHEMBL2362975,,No relevant target,,,,pKa1,,,,6.19
18163,18163,,,1173717,[],CHEMBL634053,Dissociation constant (pKa2),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,187878,=,1,0,=,,pKa2,,,8.54,CHEMBL2362975,,No relevant target,,,,pKa2,,,,8.54
18164,18164,,,1173718,[],CHEMBL622147,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,187878,=,1,1,=,,CLogP,,,2.04,CHEMBL2362975,,No relevant target,,,,clogP,,,,2.04
18165,18165,,,1173719,[],CHEMBL631373,Partition coefficient (logD7.4),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128492,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,187878,=,1,1,=,,LogD,,,-0.94,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.94
18166,18166,,,1190555,[],CHEMBL810989,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
18167,18167,,,1190556,[],CHEMBL858070,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
18168,18168,,,1190557,[],CHEMBL881264,In vitro antibacterial activity against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
18169,18169,,,1190558,[],CHEMBL813856,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.2
18170,18170,,,1190559,[],CHEMBL810786,In vitro antibacterial activity against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
18171,18171,,,1190560,[],CHEMBL676164,In vitro antibacterial activity against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
18172,18172,,,1190561,[],CHEMBL678425,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
18173,18173,,,1190562,[],CHEMBL704187,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.2
18174,18174,,,1190563,[],CHEMBL772488,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
18175,18175,,,1190564,[],CHEMBL772489,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
18176,18176,,,1190565,[],CHEMBL639047,In vitro antibacterial activity against Acinetobacter species CMX669,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,1.56
18177,18177,,,1190566,[],CHEMBL723776,In vivo antibacterial activity against systemic infection caused by Staphylococcus aureus NCTC 10649 in mice,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.25
18178,18178,,,1190567,[],CHEMBL879114,In vivo antibacterial activity against systemic infection caused by Escherichia coli Juhl in mice,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.02
18179,18179,,,1190568,[],CHEMBL723774,In vivo antibacterial activity against systemic infection caused by Pseudomonas aeruginosa 5007 in mice,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138464,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.1
18180,18180,,,1190569,[],CHEMBL716199,In vivo dose(sc) inhibiting systemic infections caused by Staphylococcus aureus NCTC 10649 in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,1.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,1.6
18181,18181,,,1190570,[],CHEMBL716194,In vivo dose(po) inhibiting systemic infections caused by Staphylococcus aureus NCTC 10649 in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,15.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,15.5
18182,18182,,,1190571,[],CHEMBL716196,In vivo dose(sc) inhibiting systemic infections caused by Escherichia coli Juhl in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,0.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.2
18183,18183,,,1190572,[],CHEMBL716190,In vivo dose(po) inhibiting systemic infections caused by Escherichia coli Juhl in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,1.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,1.9
18184,18184,,,1190573,[],CHEMBL716197,In vivo dose(sc) inhibiting systemic infections caused by Pseudomonas aeruginosa 5007 in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,2.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,2.1
18185,18185,,,1190574,[],CHEMBL716192,In vivo dose(po) inhibiting systemic infections caused by Pseudomonas aeruginosa 5007 in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,138464,=,1,1,=,,ED50,mg.kg-1,,13.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,13.3
18186,18186,,,1201646,[],CHEMBL811498,In vitro antibacterial activity against Staphylococcus aureus FDA 2029P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
18187,18187,,,1201647,[],CHEMBL804400,In vitro antibacterial activity against Staphylococcus epidermidis IAM 1296,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
18188,18188,,,1201648,[],CHEMBL650442,In vitro antibacterial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.39
18189,18189,,,1201649,[],CHEMBL857118,In vitro antibacterial activity against Escherichia coli NHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
18190,18190,,,1201650,[],CHEMBL703023,In vitro antibacterial activity against Klebsiella pneumoniae PCI-602,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
18191,18191,,,1201651,[],CHEMBL771778,In vitro antibacterial activity against Proteus vulgaris OX-19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.05
18192,18192,,,1201652,[],CHEMBL805695,In vitro antibacterial activity against Salmonella Typhimurium IID 971,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.025
18193,18193,,,1201653,[],CHEMBL805411,In vitro antibacterial activity against Serratia,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614592,Serratia,Serratia,613.0,,,MIC,ug ml-1,UO_0000274,,0.2
18194,18194,,,1201654,[],CHEMBL764322,In vitro antibacterial activity against Pseudomonas aeruginosa IFO 3445,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
18195,18195,,,1201655,[],CHEMBL809217,In vitro antibacterial activity against Streptococcus aureus IID 803 -,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
18196,18196,,,1201656,[],CHEMBL809216,In vitro antibacterial activity against Streptococcus aureus IID 803 (po),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,184743,=,1,1,=,,ED50,mg.kg-1,,46.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,46.7
18197,18197,,,1201657,[],CHEMBL857115,In vivo antibacterial activity against Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184743,=,1,1,=,,MIC,ug.mL-1,,0.0125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0125
18198,18198,,,1201658,[],CHEMBL676897,In vivo antibacterial activity against Escherichia coli KC-14 (po),F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,184743,=,1,1,=,,ED50,mg.kg-1,,0.84,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.84
18199,18199,,,1201659,[],CHEMBL740239,Acute toxicity on oral administration in mice,T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,184743,>,1,1,>,,LD50,mg.kg-1,,4000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,4000.0
18200,18200,,,1213224,[],CHEMBL679038,Minimum inhibitory concentration in vitro against Enterobacter cloacae MA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
18201,18201,,,1213225,[],CHEMBL675310,Antibacterial activity in vitro against Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
18202,18202,,,1213226,[],CHEMBL700126,Minimum inhibitory concentration was evaluated in vitro against Klebsiella pneumoniae MGH2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
18203,18203,,,1213227,[],CHEMBL767617,Minimum inhibitory concentration was evaluated in vitro against Providencia rettgeri M1771,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
18204,18204,,,1213228,[],CHEMBL770146,Minimum inhibitory concentration was evaluated in vitro against Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
18205,18205,,,1213229,[],CHEMBL808008,Minimum inhibitory concentration was evaluated in vitro against Staphylococcus aureus H 228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
18206,18206,,,1213230,[],CHEMBL808009,Minimum inhibitory concentration was evaluated in vitro against Staphylococcus aureus UC 76,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
18207,18207,,,1213231,[],CHEMBL678056,Antibacterial activity expressed as Minimum inhibitory concentration was evaluated in vitro against Enterococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
18208,18208,,,1213232,[],CHEMBL808852,Minimum inhibitory concentration was evaluated in vitro against Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
18209,18209,,,1213233,[],CHEMBL840568,Minimum inhibitory concentration was evaluated in vitro against Streptococcus pyogenes C 203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,336503,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
18210,18210,,,1213234,[],CHEMBL676283,Antibacterial activity against Escherichia coli Vogel after oral administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336503,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.0
18211,18211,,,1213235,[],CHEMBL676284,Antibacterial activity against Escherichia coli Vogel after subcutaneous administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336503,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.3
18212,18212,,,1213236,[],CHEMBL812034,Compounds were evaluated in vivo for antibacterial activity for mouse protection against Streptococcus pyogenes C 203 after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336503,=,1,0,=,,PD50,mg kg-1,,180.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,180.0
18213,18213,,,1213237,[],CHEMBL809396,Antibacterial activity measured as mouse protection against Streptococcus pyogenes C 203 after subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126988,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,336503,=,1,0,=,,PD50,mg kg-1,,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,19.0
18214,18214,,,1236021,[],CHEMBL858058,Minimum inhibitory concentration in vitro against Staphylococcus aureus FDA 209P,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129851,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,290817,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
18215,18215,,,1236022,[],CHEMBL806093,Minimum inhibitory concentration vitro against Staphylococcus aureus No.88,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129851,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,290817,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
18216,18216,,,1236023,[],CHEMBL811350,Minimum inhibitory concentration in vitro against Streptococcus pneumoniae Type III,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129851,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,290817,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.39
18217,18217,,,1236024,[],CHEMBL679178,Minimum inhibitory concentration in vitro against Enterococcus faecalis LS-101,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129851,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,290817,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
18218,18218,,,1236025,[],CHEMBL679320,Minimum inhibitory concentration in vitro against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129851,Bioorg Med Chem Lett,1997.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,290817,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
18219,18219,,,1237647,[],CHEMBL651200,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Bacillus subtilis ATCC 6633(Bs).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.06
18220,18220,,,1237648,[],CHEMBL648546,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Bacillus cereus ATCC 11778 (Bc).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.25
18221,18221,,,1237649,[],CHEMBL813999,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Streptococcus faecalis ATCC 10541 (Sf).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18222,18222,,,1237650,[],CHEMBL810337,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Staphylococcus aureus ATCC 25178 (Sa).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18223,18223,,,1237651,[],CHEMBL812333,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Staphylococcus epidermidis ATCC 155-1 (Se).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
18224,18224,,,1237652,[],CHEMBL772724,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on Pseudomonas aeruginosa ATCC 10145 (Pa).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
18225,18225,,,1237653,[],CHEMBL857997,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on morganella morganii ATCC 8019 (Mm).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
18226,18226,,,1237654,[],CHEMBL767775,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on proteus vulgaris ATCC 8427 (Pv).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.06
18227,18227,,,1237655,[],CHEMBL704191,In vitro antibacterial activity measured as minimum inhibitory concentration was evaluated on klebsiella pneumoniae ATCC 10031 (Kp).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
18228,18228,,,1237656,[],CHEMBL857189,"In vitro antibacterial activity measured as minimum inhibitory concentration, was evaluated on Escherichia coli ATCC 23559(Ec).",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18229,18229,,,1237657,[],CHEMBL673974,"In vitro antibacterial activity measured as minimum inhibitory concentration, was evaluated on Enterobacter cloacae ATCC 23355 (Ecl).",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
18230,18230,,,1237658,[],CHEMBL718559,In vivo efficacy as ED50 against Staphylococcus aureus HS-93 by oral administration in mice.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,24920,=,1,1,=,,ED50,mg.kg-1,,45.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,45.1
18231,18231,,,1237659,[],CHEMBL718759,In vivo efficacy as ED50 against Escherichia coli HM-42 by oral administration in mice.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,24920,=,1,1,=,,ED50,mg.kg-1,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,3.0
18232,18232,,,1237660,[],CHEMBL718558,In vivo efficacy as ED50 against Pseudomonas aeruginosa HS-116 by oral administration in mice.,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,24920,=,1,1,=,,ED50,mg.kg-1,,70.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,70.0
18233,18233,,,1237661,[],CHEMBL619434,AUC in mice after oral dose (50 mg/kg),A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1128288,J Med Chem,1995.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,24920,=,1,0,=,,AUC,ug ml-1,,2.3,CHEMBL612558,,ADMET,,,,AUC,ug ml-1,UO_0000274,,2.3
18234,18234,,,1247393,[],CHEMBL857198,MIC at which cleaved DNA (linear) is observed at an intensity relative to oxolinic acid at 10 ug/mL by using Gyrase Induced DNA-Cleavage assay,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
18235,18235,,,1247394,[],CHEMBL688001,Inhibitory concentration in supercoiling inhibition Escherichia coli DNA gyrase assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,IC50,ug.mL-1,,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,I50,ug ml-1,UO_0000274,,5.3
18236,18236,,,1247395,[],CHEMBL675494,Antibacterial activity against Escherichia coli (H560),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.025
18237,18237,,,1247396,[],CHEMBL675496,Antibacterial activity against Escherichia coli (vogel),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.05
18238,18238,,,1247397,[],CHEMBL705833,Antibacterial activity against Klebsiella pneumonia (MGH-2),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.1
18239,18239,,,1247398,[],CHEMBL770156,Antibacterial activity against Pseudomonas aeruginosa (UI-18),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.4
18240,18240,,,1247399,[],CHEMBL809476,Antibacterial activity against Staphylococcus aureus (H228),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,3.1
18241,18241,,,1247400,[],CHEMBL809331,Antibacterial activity against Streptococcus pneumoniae (SV-1),F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249194,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,1.6
18242,18242,,,1284608,[],CHEMBL686514,Percent relaxation using isolated guinea pig trachea.,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131357,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,280445,=,1,0,=,,Relaxation,%,,0.0,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,,Relaxation,%,UO_0000187,,0.0
18243,18243,,Not Determined,1284609,[],CHEMBL692841,pD2 value (pD2 = -log EC50) was calculated using guinea pig trachea; ND means not determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1131357,Bioorg Med Chem Lett,1998.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,280445,,1,0,,,pD2,,,,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,,pD2,,,,
18244,18244,,,1298415,[],CHEMBL650966,Minimum inhibitory concentration (MIC) preventing growth of Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.06
18245,18245,,,1298416,[],CHEMBL648547,Minimum inhibitory concentration (MIC) preventing growth of Bacillus cereus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.25
18246,18246,,,1298417,[],CHEMBL814005,Minimum inhibitory concentration (MIC) preventing growth of Streptococcus faecalis ATCC 10541,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18247,18247,,,1298418,[],CHEMBL810299,Minimum inhibitory concentration (MIC) preventing growth of Streptococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18248,18248,,,1298419,[],CHEMBL805301,Minimum inhibitory concentration (MIC) preventing growth of Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
18249,18249,,,1298420,[],CHEMBL878534,Minimum inhibitory concentration (MIC)preventing growth of Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
18250,18250,,,1298421,[],CHEMBL732723,Minimum inhibitory concentration (MIC) preventing growth of Morganella morganii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
18251,18251,,,1298422,[],CHEMBL769342,Minimum inhibitory concentration (MIC) preventing growth of Proteus vulgaris,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.06
18252,18252,,,1298423,[],CHEMBL704192,Minimum inhibitory concentration (MIC)preventing growth of Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
18253,18253,,,1298424,[],CHEMBL674476,Minimum inhibitory concentration (MIC)preventing growth of Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18254,18254,,,1298425,[],CHEMBL857113,Minimum inhibitory concentration (MIC)preventing growth of Enterobacter cloacae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328891,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
18255,18255,,,1298426,[],CHEMBL813312,Efficacy on systemic infections after oral administration in mice was determined against Streptococcus aureus HS-93,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,328891,=,1,1,=,,ED50,mg.kg-1,,45.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,45.1
18256,18256,,,1298427,[],CHEMBL675628,Efficacy on systemic infections after oral administration in mice was determined against Escherichia coli HM-42,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,328891,=,1,1,=,,ED50,mg.kg-1,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,3.0
18257,18257,,,1298428,[],CHEMBL764795,Efficacy on systemic infections after oral administration in mice was determined against Pseudomonas aeruginosa HS-116,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,328891,=,1,1,=,,ED50,mg.kg-1,,70.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,70.3
18258,18258,,,1298429,[],CHEMBL638250,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1126625,J Med Chem,1993.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,328891,=,1,1,=,,AUC,ng.hr.mL-1,,2300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug ml-1 hr-1,,,2.3
18259,18259,,,1411954,[],CHEMBL834894,In vitro minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
18260,18260,,Not Determined,1411955,[],CHEMBL830067,In vitro inhibitory concentration against DNA gyrase from Micrococcus luteus 934,B,,,BAO_0000190,BAO_0000225,nucleic acid format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,,1,0,,,IC50,ug.mL-1,,,CHEMBL345,,Nucleic Acid,,,,IC50,ug ml-1,UO_0000274,,
18261,18261,,,1411956,[],CHEMBL831147,In vitro minimum inhibitory concentration against Micrococcus luteus 9341 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.56
18262,18262,,,1411957,[],CHEMBL835029,In vitro minimum inhibitory concentration against Enterobacterium faecium ATCC 8043 was determined,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.78
18263,18263,,,1411958,[],CHEMBL831350,In vitro minimum inhibitory concentration against Escherichia coli Juhl was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
18264,18264,,,1411959,[],CHEMBL830818,In vitro minimum inhibitory concentration against Escherichia coli SS was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.005
18265,18265,,,1411960,[],CHEMBL831349,In vitro minimum inhibitory concentration against Escherichia coli H560 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
18266,18266,,,1411961,[],CHEMBL835278,In vitro minimum inhibitory concentration against Escherichia coli KNK 437 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
18267,18267,,,1411962,[],CHEMBL831358,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
18268,18268,,,1411963,[],CHEMBL830867,In vitro inhibitory concentration against DNA gyrase from Escherichia coli H560,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142671,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,362741,=,1,1,=,,IC50,ug.mL-1,,3.1,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,3.1
18269,18269,,,1440171,[],CHEMBL826178,Antimycobacterial activity of compound against Mycobacterium tuberculosis H37Rv at 2 ug/mL,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137114,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,372413,=,1,1,=,,Inhibition,%,,95.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,95.0
18270,18270,,,1448085,[],CHEMBL831382,Minimum inhibitory concentration required against Gram-negative Escherichia coli WT,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
18271,18271,,,1448086,[],CHEMBL831391,Minimum inhibitory concentration required against Gram-negative Escherichia coli LKY,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
18272,18272,,,1448087,[],CHEMBL831392,Minimum inhibitory concentration required against Gram-negative Escherichia coli TLC,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
18273,18273,,,1448088,[],CHEMBL831403,Minimum inhibitory concentration required against Gram-positive Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.4
18274,18274,,,1448089,[],CHEMBL831404,Minimum inhibitory concentration required against Gram-positive Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
18275,18275,,,1448090,[],CHEMBL831413,Minimum inhibitory concentration required against Gram-positive Streptococcus pyogenes,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,374113,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
18276,18276,,,1448091,[],CHEMBL835555,Concentration required to inhibit in vitro DNA gyrase activity isolated from Escherichia coli,B,,,BAO_0000181,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137174,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,374113,=,1,0,=,,Activity,uM,,0.4,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Activity,uM,UO_0000064,,0.4
18277,18277,,,1455030,[],CHEMBL825491,Ability to inhibit growth of Bacillus subtilis MTCC 121 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,22.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Growth Inhibition,mm,UO_0000016,,22.0
18278,18278,,,1455031,[],CHEMBL838335,Ability to inhibit growth of Bacillus cereus MTCC 1272 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,17.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,Growth Inhibition,mm,UO_0000016,,17.0
18279,18279,,,1455032,[],CHEMBL825494,Ability to inhibit growth of Staphylococcus aureus MTCC1430 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Growth Inhibition,mm,UO_0000016,,21.0
18280,18280,,,1455033,[],CHEMBL825492,Ability to inhibit growth of Enterococcus faecalis MTCC 439 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Growth Inhibition,mm,UO_0000016,,16.0
18281,18281,,,1455034,[],CHEMBL825495,Ability to inhibit growth of Pseudomonas aeruginosa MTCC 1034 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,18.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Growth Inhibition,mm,UO_0000016,,18.0
18282,18282,,,1455035,[],CHEMBL838334,Ability to inhibit growth of Proteus vulgaris MTCC744 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,19.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,Growth Inhibition,mm,UO_0000016,,19.0
18283,18283,,,1455036,[],CHEMBL825493,Ability to inhibit growth of Klebsiella pneumoniae MTCC 109 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,18.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Growth Inhibition,mm,UO_0000016,,18.0
18284,18284,,,1455037,[],CHEMBL838336,Ability to inhibit growth of Shigella sonnei MTCC 2957 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,21.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,Growth Inhibition,mm,UO_0000016,,21.0
18285,18285,,,1455038,[],CHEMBL838333,Ability to inhibit growth of Escherichia coli MTCC 42 was determined,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137910,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,376155,=,1,0,=,,Growth Inhibition,mm,,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Growth Inhibition,mm,UO_0000016,,22.0
18286,18286,,,1466048,[],CHEMBL831747,Antibacterial activity against methicillin susceptible Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138748,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,379690,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18287,18287,,,1466049,[],CHEMBL831738,Antibacterial activity against methicillin resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138748,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,379690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18288,18288,,,1466142,[],CHEMBL830489,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138748,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,379690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
18289,18289,,,1466143,[],CHEMBL830488,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138748,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,379690,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
18290,18290,,,1466144,[],CHEMBL830490,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138748,J Med Chem,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,379690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18291,18291,,,1477844,[],CHEMBL834664,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv pFPCA1 in green fluorescent protein microplate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142818,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,382488,<,1,1,<,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
18292,18292,,,1495613,[],CHEMBL838962,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,386217,=,1,0,=,,pKa1,,,6.39,CHEMBL2362975,,No relevant target,,,,pKa1,,,,6.39
18293,18293,,,1495614,[],CHEMBL830510,Minimum inhibitory concentration against Streptococcus agalactiae ATCC 13813,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,2.0
18294,18294,,,1495711,[],CHEMBL831781,Minimum inhibitory concentration against Streptococcus sanguis ATCC 10556,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,2.0
18295,18295,,,1495712,[],CHEMBL830805,Minimum inhibitory concentration against Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.008
18296,18296,,,1495713,[],CHEMBL831389,Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
18297,18297,,,1495714,[],CHEMBL831791,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18298,18298,,,1495715,[],CHEMBL831421,Minimum inhibitory concentration against Bacteroides vulgatus ATCC 29327,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,8.0
18299,18299,,,1495716,[],CHEMBL875740,Minimum inhibitory concentration against Staphylococcus aureus ISP 794,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
18300,18300,,,1495717,[],CHEMBL831793,Minimum inhibitory concentration against Staphylococcus aureus gyrA mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
18301,18301,,,1495718,[],CHEMBL831792,Minimum inhibitory concentration against Staphylococcus aureus grlA mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
18302,18302,,,1495719,[],CHEMBL830553,Minimum inhibitory concentration against Staphylococcus aureus gyrA/grlA double mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
18303,18303,,,1495720,[],CHEMBL838964,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,386217,=,1,0,=,,pKa2,,,8.68,CHEMBL2362975,,No relevant target,,,,pKa2,,,,8.68
18304,18304,,,1495721,[],CHEMBL826975,Inhibition of supercoiling activity of DNA gyrase from Staphylococcus aureus ISP 794,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,IC50,ug.mL-1,,5.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,5.0
18305,18305,,,1495722,[],CHEMBL829465,Inhibition of supercoiling activity of topoisomerase IV from Staphylococcus aureus ISP 794; Range = 2.5-5 ug/mL,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,IC50,ug.mL-1,,5.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,ug ml-1,UO_0000274,,5.0
18306,18306,,,1495723,[],CHEMBL840008,Stimulation of DNA cleavage complex formation in DNA gyrase from Staphylococcus aureus ISP 794; Range = 30-50 ug/ml,B,,,BAO_0000187,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,CC50,ug.mL-1,,50.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,CC50,ug ml-1,UO_0000274,,50.0
18307,18307,,,1495724,[],CHEMBL840010,Stimulation of DNA cleavage complex formation of topoisomerase IV from Staphylococcus aureus ISP 794; Range = 1.25-2.5 ug/mL,B,,,BAO_0000187,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,CC50,ug.mL-1,,2.5,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,CC50,ug ml-1,UO_0000274,,2.5
18308,18308,,,1495725,[],CHEMBL876455,Partition coefficient (logD2.0),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,386217,=,1,1,=,,LogD,,,-1.36,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.36
18309,18309,,,1495726,[],CHEMBL827011,Partition coefficient (logD7.4),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,386217,=,1,1,=,,LogD,,,-0.98,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.98
18310,18310,,,1495727,[],CHEMBL831777,Minimum inhibitory concentration against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
18311,18311,,,1495728,[],CHEMBL875746,Minimum inhibitory concentration against Staphylococcus haemolyticus ATCC 29970,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.25
18312,18312,,,1495729,[],CHEMBL830690,Minimum inhibitory concentration against Staphylococcus saprophyticus ATCC 15305,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.5
18313,18313,,,1495730,[],CHEMBL830804,Minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
18314,18314,,,1495731,[],CHEMBL831326,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18315,18315,,,1495732,[],CHEMBL830503,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 6303,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18316,18316,,,1495733,[],CHEMBL831794,Minimum inhibitory concentration against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386217,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
18317,18317,,Susceptible,1498427,[],CHEMBL836753,Susceptibility testing against Pseudomonas aeruginosa ATCC 27853; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18318,18318,,Susceptible,1498428,[],CHEMBL836761,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH18; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18319,18319,,Susceptible,1498429,[],CHEMBL836762,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH19; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18320,18320,,Susceptible,1498430,[],CHEMBL836763,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH20; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18321,18321,,Susceptible,1498431,[],CHEMBL836764,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH21; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18322,18322,,Susceptible,1498542,[],CHEMBL836137,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH22; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18323,18323,,Susceptible,1498543,[],CHEMBL836138,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH23; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18324,18324,,Susceptible,1498544,[],CHEMBL836139,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH24; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18325,18325,,Susceptible,1498545,[],CHEMBL836140,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH25; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18326,18326,,Resistant,1498546,[],CHEMBL835984,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH01; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18327,18327,,Resistant,1498547,[],CHEMBL835985,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH02; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18328,18328,,Resistant,1498548,[],CHEMBL835986,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH03; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18329,18329,,Resistant,1498549,[],CHEMBL835987,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH04; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18330,18330,,Resistant,1498550,[],CHEMBL835988,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH05; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18331,18331,,Resistant,1498551,[],CHEMBL835989,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH06; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18332,18332,,Resistant,1498552,[],CHEMBL835990,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH07; R=Resistant,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18333,18333,,Susceptible,1498553,[],CHEMBL836760,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH17; S=Susceptible,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,394466,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18334,18334,,,1500403,[],CHEMBL830697,Minimum inhibitory concentration against Staphylococcus aureus ATCC 33591 (resistant to methicillin),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143581,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,389088,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
18335,18335,,,1500404,[],CHEMBL826773,Effect on bacterial membrane integrity was determined by using SYTO9 green fluorescent nucleic acid strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143581,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,389088,=,1,0,=,,Membrane integrity,%,,102.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Membrane integrity,%,UO_0000187,,102.0
18336,18336,,,1500405,[],CHEMBL877077,Percent lysis of human erythrocytes after exposed to test compound was measured as hemolysis,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143581,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,389088,=,1,0,=,,Hemolysis,%,,0.0,CHEMBL612558,,ADMET,,,,Hemolysis,%,UO_0000187,,0.0
18337,18337,,,1504552,[],CHEMBL828190,Tested for fraction of oral dose absorbed orally in humans,A,,,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143634,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,390337,=,1,0,=,,Activity,%,,69.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,69.0
18338,18338,,,1507571,[],CHEMBL831752,In vitro minimum inhibitory concentration against Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143629,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390556,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
18339,18339,,,1507572,[],CHEMBL830560,In vitro minimum inhibitory concentration against Streptococcus pneumoniae type III,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143629,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390556,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.78
18340,18340,,,1507573,[],CHEMBL831748,In vitro minimum inhibitory concentration against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143629,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390556,<=,1,1,<=,,MIC,ug.mL-1,,0.0063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0063
18341,18341,,,1507574,[],CHEMBL830934,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa IID1210,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143629,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390556,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
18342,18342,,,1507575,[],CHEMBL832740,Inhibitory concentration against DNA gyrase of Staphylococcus aureus,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1143629,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390556,=,1,1,=,,IC50,ug.mL-1,,20.1,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,20.1
18343,18343,,,1523953,[],CHEMBL829152,Inhibitory concentration against potassium channel HERG,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139598,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/Nanomolar,395972,=,1,1,=,,IC50,nM,,954992.59,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.02
18344,18344,,,1603664,[],CHEMBL880346,Binding constant (K) against Tat/TAR using 1:1 quinolone/Mg2+ complex done at 25 degree C with pH 7.5,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141051,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,401097,=,1,0,=,,K,1/M,,790.0,CHEMBL4011,Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1),Human immunodeficiency virus type 1 Tat protein,11706.0,,,K,1/M,,,790.0
18345,18345,,,1611624,[],CHEMBL871611,In vitro minimum inhibitory concentration against Bacillus subtilis upon incubation at 37 degree C for 16 to 24 h,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.078
18346,18346,,,1611625,[],CHEMBL871614,In vitro minimum inhibitory concentration against Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
18347,18347,,,1611626,[],CHEMBL871616,In vitro minimum inhibitory concentration against Staphylococcus aureus (Smith) upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.078
18348,18348,,,1611627,[],CHEMBL871622,In vitro minimum inhibitory concentration against Methicillin-resistant Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,>,1,1,>,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
18349,18349,,,1611628,[],CHEMBL871613,In vitro minimum inhibitory concentration against Enterococcus faecalis upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.625
18350,18350,,,1611629,[],CHEMBL871612,In vitro minimum inhibitory concentration against Enterococcus fecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,5.0
18351,18351,,,1611630,[],CHEMBL871621,In vitro minimum inhibitory concentration against Vancomycin resistant Enterococci faecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403414,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,20.0
18352,18352,,,1614703,[],CHEMBL884142,Minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18353,18353,,,1614704,[],CHEMBL884143,Minimum inhibitory concentration against Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
18354,18354,,,1614705,[],CHEMBL884139,Minimum inhibitory concentration against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.015
18355,18355,,,1614706,[],CHEMBL884140,Minimum inhibitory concentration against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
18356,18356,,,1614707,[],CHEMBL884141,Minimum inhibitory concentration against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18357,18357,,,1614708,[],CHEMBL883206,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404164,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
18358,18358,,,1661469,[],CHEMBL870550,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141859,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,410443,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
18359,18359,,,1661557,[],CHEMBL870551,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141859,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,410443,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
18360,18360,,,1661593,[],CHEMBL870552,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141859,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,410443,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
18361,18361,,,1661629,[],CHEMBL870553,Antibacterial activity against Proteus vulgaris,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141859,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,410443,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,12.5
18362,18362,,,1661665,[],CHEMBL870554,Antibacterial activity against Bacillis anthracoides,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1141859,Bioorg Med Chem Lett,2005.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,410443,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL4372,Bacillus anthracis,Anthrax lethal factor,1392.0,,,MIC,ug ml-1,UO_0000274,,12.5
18363,18363,,,1667302,[],CHEMBL864624,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148591,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417966,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
18364,18364,,,1667303,[],CHEMBL864625,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148591,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417966,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18365,18365,,,1667304,[],CHEMBL869436,Inhibition of DNA gyrase supercoiling in Escherichia coli ATCC 25922,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148591,J Med Chem,2006.0,"{'bei': '19.69', 'le': '0.37', 'lle': '4.94', 'sei': '8.75'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.52,0,http://www.openphacts.org/units/Nanomolar,417966,=,1,1,=,,IC50,nM,,300.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.3
18366,18366,,,1667305,[],CHEMBL854373,Inhibition of topoisomerase 4 decatenation in Staphylococcus aureus ATCC 29213,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1148591,J Med Chem,2006.0,"{'bei': '17.02', 'le': '0.32', 'lle': '4.06', 'sei': '7.56'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.64,0,http://www.openphacts.org/units/Nanomolar,417966,=,1,1,=,,IC50,nM,,2300.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,2.3
18367,18367,,Not Active,1683698,[],CHEMBL861887,Binding affinity to Bacillus subtilis DNA polymerase3C,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,428200,,1,0,,,Ki,,,,CHEMBL3897,Bacillus subtilis (strain 168),DNA polymerase III,224308.0,,,Ki,,,,
18368,18368,,,1683725,[],CHEMBL862001,Antibacterial activity against Bacillus subtilis BD54,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.156
18369,18369,,,1683752,[],CHEMBL862003,Antibacterial activity against Staphylococcus aureus 25293,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.313
18370,18370,,,1683780,[],CHEMBL862058,Antibacterial activity against Staphylococcus aureus smith,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
18371,18371,,,1683806,[],CHEMBL862059,Antibacterial activity against methicillin resistant Staphylococcus aureus MRSA 1094,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
18372,18372,,,1683833,[],CHEMBL862060,Antibacterial activity against Enterococcus faecalis 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.625
18373,18373,,,1683853,[],CHEMBL862061,Antibacterial activity against Enterococcus faecium 19434,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,10.0
18374,18374,,,1683887,[],CHEMBL862062,Antibacterial activity against Vancomycin resistant Enterococcus faecium VRE 700802,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,80.0
18375,18375,,,1683914,[],CHEMBL862063,Antibacterial activity against Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.313
18376,18376,,,1684023,[],CHEMBL862064,Inhibition of Bacillus subtilis topoisomerase4 activity,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,IC50,ug.mL-1,,1.9,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.9
18377,18377,,,1684029,[],CHEMBL862002,Inhibition of Bacillus subtilis gyrase activity,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428200,=,1,1,=,,IC50,ug.mL-1,,0.74,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.74
18378,18378,,,1689288,[],CHEMBL866051,Cytotoxicity against Hep2 cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,438114,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
18379,18379,,,1689576,[],CHEMBL865340,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
18380,18380,,,1689577,[],CHEMBL865341,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.22,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.22
18381,18381,,,1689578,[],CHEMBL865342,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
18382,18382,,,1689579,[],CHEMBL865343,Inhibitory activity against Staphylococcus aureus ATCC 29213 wild type Topo 4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,"{'bei': '18.11', 'le': '0.34', 'lle': '4.42', 'sei': '8.05'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.0,0,http://www.openphacts.org/units/Nanomolar,438114,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,1.0
18383,18383,,,1689971,[],CHEMBL867184,Antibacterial activity against Haemophilus influenzae type b ACH-0056,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.018,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.018
18384,18384,,,1689982,[],CHEMBL867189,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18385,18385,,,1689983,[],CHEMBL867188,Antibacterial activity against Klebsiella pneumoniae ATCC 13883,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.033,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.033
18386,18386,,,1689985,[],CHEMBL867187,Antibacterial activity against Salmonella Typhimurium ATCC 14028,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.018,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.018
18387,18387,,,1689987,[],CHEMBL867186,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.28,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.28
18388,18388,,,1689989,[],CHEMBL867185,Antibacterial activity against Moraxella catarrhalis ATCC 8176,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.033,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.033
18389,18389,,,1689991,[],CHEMBL867183,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.56,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.56
18390,18390,,,1689993,[],CHEMBL867182,Antibacterial activity against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.28,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.28
18391,18391,,,1689994,[],CHEMBL867181,Antibacterial activity against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,0.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.56
18392,18392,,,1690041,[],CHEMBL867180,Antibacterial activity against Enterococcus faecium ATCC 49032,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438114,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
18393,18393,,,1690286,[],CHEMBL865324,Inhibition of recombinant HIV1 integrase strand transfer activity,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138174,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,433305,>,1,1,>,,IC50,nM,,100000.0,CHEMBL3471,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 integrase,11676.0,,,IC50,nM,UO_0000065,,100000.0
18394,18394,,,1695163,[],CHEMBL865595,Antimicrobial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441543,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
18395,18395,,,1695169,[],CHEMBL865596,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441543,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18396,18396,,,1695170,[],CHEMBL865597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441543,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
18397,18397,,,1695177,[],CHEMBL864433,Cytotoxicity against human Hep2 laryngeal carcinoma cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,441543,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
18398,18398,,,1695450,[],CHEMBL864372,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '18.11', 'le': '0.34', 'lle': '4.42', 'sei': '8.05'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.0,1,http://www.openphacts.org/units/Nanomolar,441543,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,1.0
18399,18399,,,1695469,[],CHEMBL863775,Inhibitory activity against wild type Escherichia coli gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '19.69', 'le': '0.37', 'lle': '4.94', 'sei': '8.75'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.52,1,http://www.openphacts.org/units/Nanomolar,441543,=,1,1,=,,IC50,nM,,300.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.3
18400,18400,,,1725405,[],CHEMBL866308,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147718,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,476852,=,1,1,=,,MIC,nM,,467735.14,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-Log MIC,,UO_0000065,,3.33
18401,18401,,,1725434,[],CHEMBL866309,Antibacterial activity against Micrococcus luteus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147718,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,476852,=,1,1,=,,MIC,nM,,467735.14,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,-Log MIC,,UO_0000065,,3.33
18402,18402,,,1725463,[],CHEMBL866310,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147718,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,476852,=,1,1,=,,MIC,nM,,467735.14,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-Log MIC,,UO_0000065,,3.33
18403,18403,,,1738023,[],CHEMBL868687,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
18404,18404,,,1738027,[],CHEMBL868686,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
18405,18405,,,1738030,[],CHEMBL868685,Antibacterial activity against Escherichia coli ATCC 8739 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
18406,18406,,,1738035,[],CHEMBL868681,Antibacterial activity against Bacillus subtilis ATCC 6633 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.025
18407,18407,,,1738040,[],CHEMBL868684,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
18408,18408,,,1738044,[],CHEMBL870495,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
18409,18409,,,1738048,[],CHEMBL868689,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
18410,18410,,,1738050,[],CHEMBL868678,Antibacterial activity against Staphylococcus aureus ATCC 6538p by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512272,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
18411,18411,,,1754910,[],CHEMBL871035,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 6303,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146867,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,552453,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18412,18412,,,1754935,[],CHEMBL871034,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 7257,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146867,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,552453,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18413,18413,,,1754962,[],CHEMBL871033,Inhibition on Streptococcus pneumoniae translation by uncoupled translation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1146867,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,552453,=,1,1,=,,IC50,nM,,200000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,IC50,uM,UO_0000065,,200.0
18414,18414,,Not Determined,1757597,[],CHEMBL853431,Antibacterial activity against Klebsiella pneumoniae ATCC 8308 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,541902,,1,0,,,IZ,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,,,,
18415,18415,,Not Determined,1757598,[],CHEMBL853430,Antibacterial activity against Salmonella enterica ATCC 13311 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,541902,,1,0,,,IZ,,,,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,IZ,,,,
18416,18416,,Not Determined,1757599,[],CHEMBL853429,Antibacterial activity against Escherichia coli ATCC 33475 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,541902,,1,0,,,IZ,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,,,,
18417,18417,,Not Determined,1757600,[],CHEMBL853428,Antibacterial activity against Escherichia coli X580 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,541902,,1,0,,,IZ,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,,,,
18418,18418,,,1757601,[],CHEMBL853427,Antibacterial activity against PSE1 beta-lactamase Pseudomonas aeruginosa IV-3-13 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,35.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,35.0
18419,18419,,,1757602,[],CHEMBL853426,Antibacterial activity against ampC beta-lactamase Enterobacter cloacae P99 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,30.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,30.0
18420,18420,,,1757603,[],CHEMBL853425,Antibacterial activity against TEM1 beta-lactamase Escherichia coli IV-3-2 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,27.0
18421,18421,,,1757604,[],CHEMBL853424,Antibacterial activity against wild type Escherichia coli DC0 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,25.0
18422,18422,,,1757605,[],CHEMBL853421,Antibacterial activity against wild type Mycobacterium vaccae IMET10670 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,38.0,CHEMBL614981,Mycobacterium,Mycobacterium,1763.0,,,IZ,mm,UO_0000016,,38.0
18423,18423,,,1757606,[],CHEMBL870347,Antibacterial activity against VRE Enterococcus faecalis 1528 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,24.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,IZ,mm,UO_0000016,,24.0
18424,18424,,,1757607,[],CHEMBL870346,Antibacterial activity against MRSA Staphylococcus aureus 134/93 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,0.0
18425,18425,,Not Determined,1757656,[],CHEMBL853432,Antifungal activity against Candida albicans BMSY 212 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,541902,,1,0,,,IZ,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IZ,,,,
18426,18426,,,1757686,[],CHEMBL870345,Antibacterial activity against wild type Staphylococcus aureus SG 511 by agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,541902,=,1,1,=,,IZ,mm,,29.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,29.0
18427,18427,,,1773257,[],CHEMBL911269,Antibacterial activity against Enterococcus faecalis ATCCC29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,12.5
18428,18428,,,1773265,[],CHEMBL911270,Antibacterial activity against Escherichia coli 256,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
18429,18429,,,1773273,[],CHEMBL911271,Antibacterial activity against Escherichia coli 292,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
18430,18430,,,1773281,[],CHEMBL912381,Antibacterial activity against Listeria monocytogenes 3,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.5
18431,18431,,,1773289,[],CHEMBL912382,Antibacterial activity against Listeria monocytogenes 4,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.0
18432,18432,,,1773297,[],CHEMBL912383,Antibacterial activity against Listeria monocytogenes 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.5
18433,18433,,,1773305,[],CHEMBL912384,Antibacterial activity against Listeria monocytogenes 6,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.5
18434,18434,,,1773313,[],CHEMBL912385,Antibacterial activity against Listeria monocytogenes 7,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.0
18435,18435,,,1773321,[],CHEMBL912386,Antibacterial activity against Listeria monocytogenes 8,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.0
18436,18436,,,1773329,[],CHEMBL912387,Antibacterial activity against Listeria monocytogenes ATCC 4428,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.5
18437,18437,,,1773337,[],CHEMBL912388,Antibacterial activity against Staphylococcus aureus 341,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.2
18438,18438,,,1773345,[],CHEMBL912389,Antibacterial activity against Staphylococcus aureus 343,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18439,18439,,,1773353,[],CHEMBL912390,Antibacterial activity against Staphylococcus aureus K28,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18440,18440,,,1773361,[],CHEMBL912391,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18441,18441,,,1773369,[],CHEMBL912392,Antibacterial activity against Staphylococcus haemolyticus ATCC 2997,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,2.5
18442,18442,,,1773377,[],CHEMBL912393,Antibacterial activity against Staphylococcus saprophyticus ATCC 15305,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,1.0
18443,18443,,,1773385,[],CHEMBL912394,Antibacterial activity against Citrobacter 224,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL614437,Citrobacter,Citrobacter,544.0,,,MIC,ug ml-1,UO_0000274,,25.0
18444,18444,,,1773393,[],CHEMBL912395,Antibacterial activity against Streptococcus 42,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137378,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,603866,>,1,1,>,,MIC,ug.mL-1,,5.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,5.0
18445,18445,,,1775037,[],CHEMBL856671,Inhibition of Escherichia coli gyrase,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.7,0,http://www.openphacts.org/units/Nanomolar,586690,=,1,1,=,,IC50,nM,,200.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.2
18446,18446,,,1775319,[],CHEMBL908930,Antibacterial activity against Escherichia coli EC1-10,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18447,18447,,,1775320,[],CHEMBL856589,Antibacterial activity against Klebsiella pneumonia KP2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
18448,18448,,,1775321,[],CHEMBL856591,Antibacterial activity against Providencia rettgeri PR9,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.06
18449,18449,,,1775322,[],CHEMBL856592,Antibacterial activity against Pseudomonas aeruginosa PA7,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
18450,18450,,,1775323,[],CHEMBL856593,Antibacterial activity against Escherichia coli EC2026,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
18451,18451,,,1775324,[],CHEMBL856594,Antibacterial activity against Escherichia coli EC2549,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
18452,18452,,,1775355,[],CHEMBL856595,Antibacterial activity against Haemophilus influenzae HI3542,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.008
18453,18453,,,1775356,[],CHEMBL856596,Antibacterial activity against Moraxella catarrhalis BC-3531,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.03
18454,18454,,,1775357,[],CHEMBL856597,Antibacterial activity against Staphylococcus aureus SA1417,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18455,18455,,,1775358,[],CHEMBL856598,Antibacterial activity against Staphylococcus aureus UC-76 SA-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
18456,18456,,,1775359,[],CHEMBL856599,Antibacterial activity against Staphylococcus aureus SA2552,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
18457,18457,,,1775360,[],CHEMBL855582,Antibacterial activity against Staphylococcus aureus SA2554,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
18458,18458,,,1775361,[],CHEMBL855583,Antibacterial activity against Staphylococcus aureus SA2558,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18459,18459,,,1775362,[],CHEMBL855584,Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1417,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18460,18460,,,1775363,[],CHEMBL855585,Antibacterial activity against ciprofolxacin-resistant Staphylococcus aureus SA2017,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18461,18461,,,1775364,[],CHEMBL856604,Antibacterial activity against Enterococcus faecalis MGH2 EF1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18462,18462,,,1775365,[],CHEMBL856605,Antibacterial activity against Enterococcus faecalis EF1-3524,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,32.0
18463,18463,,,1775366,[],CHEMBL856606,Antibacterial activity against vancomycin-resistant Enterococcus faecium EF4-3489,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,64.0
18464,18464,,,1775367,[],CHEMBL856607,Antibacterial activity against Streptococcus pneumonia SVI SP3,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18465,18465,,,1775368,[],CHEMBL856608,Antibacterial activity against quinolone-resistant Streptococcus pneumonia SP3763,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18466,18466,,,1775369,[],CHEMBL856609,Antibacterial activity against Streptococcus pyogenes C203 SP1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
18467,18467,,,1801664,[],CHEMBL910494,Cytotoxicity against human Hep2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,621374,>,1,1,>,,CC50,nM,,100000.0,CHEMBL612558,,ADMET,,,,CC50,uM,UO_0000065,,100.0
18468,18468,,,1801678,[],CHEMBL910493,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621374,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
18469,18469,,,1804129,[],CHEMBL910510,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.0,0,http://www.openphacts.org/units/Nanomolar,621374,=,1,1,=,,IC50,nM,,1000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.0
18470,18470,,,1804130,[],CHEMBL910511,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,"{'bei': '12.70', 'le': '0.24', 'lle': '2.63', 'sei': '5.64'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.21,0,http://www.openphacts.org/units/Nanomolar,621374,=,1,1,=,,IC50,nM,,62000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,62.0
18471,18471,,,1804131,[],CHEMBL910512,Inhibition of human topoisomerase 2 by DNA cleavage assay,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,621374,>,1,0,>,,EC2,uM,,150.0,CHEMBL1806,Homo sapiens,DNA topoisomerase II alpha,9606.0,,,EC2,uM,UO_0000064,,150.0
18472,18472,,,1804132,[],CHEMBL910513,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621374,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18473,18473,,,1804189,[],CHEMBL910514,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 273/T/T/T,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621374,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18474,18474,,,1804190,[],CHEMBL910515,Cytotoxicity against human HepG2 cells after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,621374,>,1,1,>,,CC50,nM,,100000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CC50,uM,UO_0000065,,100.0
18475,18475,,Not Determined,1804191,[],CHEMBL910518,Cytotoxicity against rat hepatocytes after 48 hrs,F,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,621374,,1,0,,,CC50,,,,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,CC50,,,,
18476,18476,,,1804660,[],CHEMBL910472,Antibacterial activity against Escherichia coli K12,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138862,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,620828,=,1,1,=,,MIC,nM,,38.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.038
18477,18477,,,1804661,[],CHEMBL910472,Antibacterial activity against Escherichia coli K12,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138862,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,620828,=,1,0,=,,MBC,uM,,0.076,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM,UO_0000064,,0.076
18478,18478,,,1804663,[],CHEMBL910474,"Ratio, MIC/MBC for Escherichia coli K12",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138862,J Med Chem,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,620828,=,1,0,=,,Ratio,,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,0.5
18479,18479,,Not Determined,1808398,[],CHEMBL911320,Cytotoxicity against Vero cells,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,622828,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
18480,18480,,,1808429,[],CHEMBL911305,Antibacterial activity against Escherichia coli DC0,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.4
18481,18481,,,1808430,[],CHEMBL911306,Antibacterial activity against Escherichia coli DC2 permeability mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,<,1,1,<,,MIC,nM,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.1
18482,18482,,,1808431,[],CHEMBL911307,Antibacterial activity against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,<,1,1,<,,MIC,nM,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,uM,UO_0000065,,0.1
18483,18483,,,1808432,[],CHEMBL911308,Antibacterial activity against Micrococcus luteus ATCC 10240,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,uM,UO_0000065,,25.0
18484,18484,,,1808433,[],CHEMBL911309,Antibacterial activity against Pseudomonas aeruginosa KW 799,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,800.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,0.8
18485,18485,,,1808434,[],CHEMBL911310,Antibacterial activity against Pseudomonas aeruginosa KW 799/ 61 permeability mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,0.4
18486,18486,,,1808435,[],CHEMBL911311,Antibacterial activity against Mycobacterium vaccae IMET10670,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,800.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,,MIC,uM,UO_0000065,,0.8
18487,18487,,,1808436,[],CHEMBL911312,Antibacterial activity against Mycobacterium smegmatis SG987,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,800.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,0.8
18488,18488,,,1808437,[],CHEMBL911313,Antibacterial activity against Mycobacterium aurum SB66,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,100.0,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,,MIC,uM,UO_0000065,,0.1
18489,18489,,,1808438,[],CHEMBL911314,Antibacterial activity against Mycobacterium aurum DSM 43436,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,100.0,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,,MIC,uM,UO_0000065,,0.1
18490,18490,,,1808439,[],CHEMBL911315,Antibacterial activity against Mycobacterium fortuitum B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,200.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,uM,UO_0000065,,0.2
18491,18491,,,1808440,[],CHEMBL911316,Antibacterial activity against Staphylococcus aureus SG 511,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.8
18492,18492,,,1808441,[],CHEMBL911317,Antibacterial activity against Staphylococcus aureus 134/93 MRSA,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
18493,18493,,,1808442,[],CHEMBL911318,Antibacterial activity against Enterococcus faecalis 1528 VRE,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,1560.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,1.56
18494,18494,,,1808443,[],CHEMBL911319,Antibacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1139710,Bioorg Med Chem Lett,2006.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,622828,=,1,1,=,,MIC,nM,,1800.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.8
18495,18495,,,1824716,[],CHEMBL910799,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 26 containing gyrA C261A mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,4.0
18496,18496,,,1826980,[],CHEMBL909713,Bacteriostatic activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625567,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
18497,18497,,,1826983,[],CHEMBL910810,Bacteriostatic activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625567,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
18498,18498,,,1827244,[],CHEMBL855936,Inhibition of Bacillus subtilis topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142158,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.77,0,http://www.openphacts.org/units/Nanomolar,625703,=,1,1,=,,IC50,nM,,1700.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.7
18499,18499,,,1827248,[],CHEMBL855937,Inhibition of Bacillus subtilis gyrase,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142158,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.2,0,http://www.openphacts.org/units/Nanomolar,625703,=,1,1,=,,IC50,nM,,6300.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,6.3
18500,18500,,,1828951,[],CHEMBL908125,Cytotoxicity against primary human osteoblasts at 400 ug/ml assessed as LDH release after 24 hrs,A,,,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,625754,=,1,0,=,,Activity,%,,10.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,10.0
18501,18501,,Active,1828963,[],CHEMBL909771,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA at 10 ug/ml after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625754,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
18502,18502,,,1828966,[],CHEMBL909772,Increase in lactate production in primary human osteoblasts at 25 to 50 ug/ml by ELISA,F,,,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,625754,=,1,0,=,,Activity,%,,10.0,CHEMBL612582,,Osteoblast,,,,Activity,%,UO_0000187,,10.0
18503,18503,,,1829041,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,70.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC20,ug ml-1,UO_0000274,,70.0
18504,18504,,,1829042,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,1,=,,IC50,ug.mL-1,,170.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,ug ml-1,UO_0000274,,170.0
18505,18505,,,1829043,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL612582,,Osteoblast,,,,IC50,ug ml-1,UO_0000274,,400.0
18506,18506,,,1829044,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,260.0,CHEMBL612582,,Osteoblast,,,,IC20,ug ml-1,UO_0000274,,260.0
18507,18507,,,1829045,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,80.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,80.0
18508,18508,,,1829046,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,1,=,,IC50,ug.mL-1,,160.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,160.0
18509,18509,,,1829047,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,1,=,,IC50,ug.mL-1,,150.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,150.0
18510,18510,,,1829048,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,60.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,60.0
18511,18511,,,1829049,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,100.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,100.0
18512,18512,,,1829050,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,1,=,,IC50,ug.mL-1,,290.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,290.0
18513,18513,,,1829051,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,1,=,,IC50,ug.mL-1,,120.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,120.0
18514,18514,,,1829052,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625754,=,1,0,=,,IC20,ug ml-1,,70.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,70.0
18515,18515,,,1829238,[],CHEMBL909707,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 4 containing gyrA C261G mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,4.0
18516,18516,,,1829274,[],CHEMBL912048,Inhibitory activity against azide-resistant Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18517,18517,,,1829280,[],CHEMBL912049,Inhibitory activity against Escherichia coli 12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
18518,18518,,,1829286,[],CHEMBL912050,Inhibitory activity against Klebsiella pneumoniae 12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
18519,18519,,,1829292,[],CHEMBL912051,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
18520,18520,,,1829298,[],CHEMBL912052,Inhibitory activity against Klebsiella pneumoniae 35,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
18521,18521,,,1829304,[],CHEMBL912053,Inhibitory activity against azide-resistant Escherichia coli J53 T35,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
18522,18522,,,1829310,[],CHEMBL912054,Inhibitory activity against Klebsiella pneumoniae 07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
18523,18523,,,1829316,[],CHEMBL912055,Inhibitory activity against azide-resistant Escherichia coli J53 T07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
18524,18524,,,1829322,[],CHEMBL912056,Inhibitory activity against Klebsiella pneumoniae 03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
18525,18525,,,1829328,[],CHEMBL912057,Inhibitory activity against azide-resistant Escherichia coli J53 T03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
18526,18526,,,1829334,[],CHEMBL912058,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625670,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
18527,18527,,,1831713,[],CHEMBL908132,Antimicrobial activity against Streptococcus pneumoniae R6,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18528,18528,,,1832270,[],CHEMBL909708,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 14 containing gyrA A272G mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,16.0
18529,18529,,,1832271,[],CHEMBL909709,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 12 containing gyrA G271A mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,16.0
18530,18530,,,1832272,[],CHEMBL909710,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 4 containing gyrA G271T mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,8.0
18531,18531,,,1832273,[],CHEMBL909711,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 26695 containing gyrA A272G mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,32.0
18532,18532,,,1832274,[],CHEMBL909712,Antimicrobial activity against ciprofloxacin-resistant Helicobacter pylori 26695 containing gyrA C261A mutation by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142130,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625564,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug/L,UO_0000274,,32.0
18533,18533,,Active,1832968,[],CHEMBL910811,Bactericidal activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625567,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18534,18534,,Active,1833507,[],CHEMBL910994,Inhibition of DNA synthesis in Staphylococcus aureus ATCC 29213 assessed as [3H]thymidine incorporation,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625907,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
18535,18535,,Not Active,1833508,[],CHEMBL910995,Inhibition of RNA synthesis in Staphylococcus aureus ATCC 29213 assessed as [3H]uridine incorporation,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625907,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
18536,18536,,Not Active,1833509,[],CHEMBL910996,Inhibition of protein synthesis in Staphylococcus aureus ATCC 29213 assessed as [3H]aminoacid incorporation,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625907,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
18537,18537,,,1833547,[],CHEMBL910998,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18538,18538,,,1833550,[],CHEMBL910999,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173N mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18539,18539,,,1833553,[],CHEMBL911000,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173I mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18540,18540,,,1833556,[],CHEMBL911001,Antibacterial activity against novobiocin-resistant Staphylococcus aureus ATCC 29213 with GyrB R144I mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18541,18541,,,1833559,[],CHEMBL911002,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173N and GrlB T166A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18542,18542,,,1833562,[],CHEMBL911003,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173I and GrlB T166A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18543,18543,,,1833565,[],CHEMBL911004,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-255 after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
18544,18544,,,1833568,[],CHEMBL911005,Antibacterial activity against novobiocin-resistant Streptococcus pneumoniae ATCC BAA-255 with GyrB S127L mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
18545,18545,,,1833573,[],CHEMBL911007,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-255 with ParE T172I mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
18546,18546,,,1833576,[],CHEMBL911008,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-255 with GyrB T172A and ParE T172A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
18547,18547,,,1833579,[],CHEMBL911009,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
18548,18548,,,1833582,[],CHEMBL911010,Antibacterial activity against Enterococcus faecalis ATCC 29212 with ParE T169A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
18549,18549,,,1833585,[],CHEMBL911011,Antibacterial activity against Enterococcus faecalis ATCC 29212 with GyrB T167A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18550,18550,,,1833588,[],CHEMBL911012,Antibacterial activity against Enterococcus faecalis ATCC 29212 with GyrB T167I mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
18551,18551,,,1833591,[],CHEMBL911013,Antibacterial activity against Enterococcus faecalis ATCC 29212 with GyrB T167I and ParE T169A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18552,18552,,,1833594,[],CHEMBL911014,Antibacterial activity against Enterococcus faecalis ATCC 29212 with GyrB T167A and ParE T169A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18553,18553,,,1833597,[],CHEMBL911015,Antibacterial activity against Haemophilus influenzae ATCC 51907 after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
18554,18554,,,1833600,[],CHEMBL911016,Antibacterial activity against novobiocin-resistant Haemophilus influenzae ATCC 51907 with GyrB R140C mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
18555,18555,,,1833603,[],CHEMBL911017,Antibacterial activity against novobiocin-resistant Haemophilus influenzae ATCC 51907 with GyrB R140H mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
18556,18556,,,1833606,[],CHEMBL911018,Antibacterial activity against novobiocin-resistant Haemophilus influenzae ATCC 51907 with GyrB R140L mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
18557,18557,,,1833609,[],CHEMBL911019,Antibacterial activity against Haemophilus influenzae ATCC 51907 with GyrB T169I mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
18558,18558,,,1833612,[],CHEMBL909296,Antibacterial activity against Staphylococcus aureus ATCC 29213 carrying plasmid expressing wild type GyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18559,18559,,,1833615,[],CHEMBL910386,Antibacterial activity against Staphylococcus aureus ATCC 29213 carrying plasmid expressing GyrB T173N mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18560,18560,,,1833618,[],CHEMBL910387,Antibacterial activity against Staphylococcus aureus ATCC 29213 carrying plasmid expressing GyrB T173I mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18561,18561,,,1833621,[],CHEMBL910388,Antibacterial activity against Staphylococcus aureus ATCC 29213 carrying plasmid expressing GyrB R144I mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18562,18562,,,1833624,[],CHEMBL909295,Antibacterial activity against Staphylococcus aureus ATCC 29213 without plasmid,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18563,18563,,,1833627,[],CHEMBL910389,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173N mutation without plasmid,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18564,18564,,,1833630,[],CHEMBL910390,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB T173I mutation without plasmid,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18565,18565,,,1833633,[],CHEMBL910391,Antibacterial activity against Staphylococcus aureus ATCC 29213 with GyrB R144I mutation without plasmid,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18566,18566,,,1833639,[],CHEMBL920817,Antibiotic susceptibility by resistance against Pseudomonas aeruginosa from samples collected from patients,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142216,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,626054,=,1,0,=,,Activity,%,,42.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,42.5
18567,18567,,,1833645,[],CHEMBL920818,Antibiotic susceptibility by resistance against MDR Pseudomonas aeruginosa from samples collected from patients,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142216,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,626054,=,1,0,=,,Activity,%,,3.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,3.3
18568,18568,,,1833651,[],CHEMBL920819,Antibiotic susceptibility by resistance against non-MDR Pseudomonas aeruginosa from samples collected from patients,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142216,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,626054,=,1,0,=,,Activity,%,,63.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,63.3
18569,18569,,,1833654,[],CHEMBL911006,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-255 with ParE T172A mutation after 18 to 20 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142193,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625907,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
18570,18570,,,1833693,[],CHEMBL856444,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,625857,=,1,0,=,,Activity,%,,78.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,78.5
18571,18571,,,1833701,[],CHEMBL855426,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,625857,=,1,0,=,,Activity,%,,8.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,8.8
18572,18572,,,1833794,[],CHEMBL908133,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18573,18573,,,1833798,[],CHEMBL908134,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18574,18574,,,1833802,[],CHEMBL908135,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,3.0
18575,18575,,,1833806,[],CHEMBL908136,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18576,18576,,,1833810,[],CHEMBL908137,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18577,18577,,,1833814,[],CHEMBL908138,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18578,18578,,,1833818,[],CHEMBL908139,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18579,18579,,,1833822,[],CHEMBL908140,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18580,18580,,,1833826,[],CHEMBL908141,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18581,18581,,,1833830,[],CHEMBL908142,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18582,18582,,,1833834,[],CHEMBL908143,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18583,18583,,,1833838,[],CHEMBL908144,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18584,18584,,,1833842,[],CHEMBL908145,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18585,18585,,,1833846,[],CHEMBL908146,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18586,18586,,,1833850,[],CHEMBL908147,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18587,18587,,,1833854,[],CHEMBL908148,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18588,18588,,,1833858,[],CHEMBL908149,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18589,18589,,,1833862,[],CHEMBL908150,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,<,1,1,<,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18590,18590,,,1834013,[],CHEMBL855355,Antibacterial activity against Streptococcus suis ATCC 43765 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18591,18591,,,1834014,[],CHEMBL855356,Antibacterial activity against Streptococcus suis BB1001 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18592,18592,,,1834015,[],CHEMBL855357,Antibacterial activity against Streptococcus suis BB1002 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18593,18593,,,1834016,[],CHEMBL855358,Antibacterial activity against Streptococcus suis BB1003 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18594,18594,,,1834017,[],CHEMBL855359,Antibacterial activity against Streptococcus suis BB1004 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18595,18595,,,1834018,[],CHEMBL855360,Antibacterial activity against Streptococcus suis BB1005 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18596,18596,,,1834019,[],CHEMBL855361,Antibacterial activity against Streptococcus suis BB1006 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,2.0
18597,18597,,,1834020,[],CHEMBL855362,Antibacterial activity against Streptococcus suis BB1007 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,8.0
18598,18598,,,1834021,[],CHEMBL855363,Antibacterial activity against Streptococcus suis BB1008 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
18599,18599,,,1834022,[],CHEMBL855364,Antibacterial activity against Streptococcus suis BB1009 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18600,18600,,,1834023,[],CHEMBL855365,Antibacterial activity against Streptococcus suis BB1010 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18601,18601,,,1834024,[],CHEMBL855366,Antibacterial activity against Streptococcus suis BB1011 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18602,18602,,,1834025,[],CHEMBL855367,Antibacterial activity against Streptococcus suis BB1012 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18603,18603,,,1834026,[],CHEMBL855368,Antibacterial activity against Streptococcus suis BB1013 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
18604,18604,,,1834027,[],CHEMBL855369,Antibacterial activity against Streptococcus suis BB1014 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
18605,18605,,,1834028,[],CHEMBL855370,Antibacterial activity against Streptococcus suis BB1015 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18606,18606,,,1834029,[],CHEMBL855371,Antibacterial activity against Streptococcus suis BB1016 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18607,18607,,,1834030,[],CHEMBL854309,Antibacterial activity against Streptococcus suis BB1017 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
18608,18608,,,1834031,[],CHEMBL854310,Antibacterial activity against Streptococcus suis ATCC 43765 in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18609,18609,,,1834032,[],CHEMBL854311,Antibacterial activity against Streptococcus suis BB1001 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18610,18610,,,1834033,[],CHEMBL855378,Antibacterial activity against Streptococcus suis BB1002 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18611,18611,,,1834034,[],CHEMBL855379,Antibacterial activity against Streptococcus suis BB1003 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18612,18612,,,1834035,[],CHEMBL855380,Antibacterial activity against Streptococcus suis BB1004 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18613,18613,,,1834036,[],CHEMBL855381,Antibacterial activity against Streptococcus suis BB1005 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,0.5
18614,18614,,,1834037,[],CHEMBL855382,Antibacterial activity against Streptococcus suis BB1006 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,1.0
18615,18615,,,1834038,[],CHEMBL873786,Antibacterial activity against Streptococcus suis BB1007 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,4.0
18616,18616,,,1834040,[],CHEMBL873787,Antibacterial activity against Streptococcus suis BB1008 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
18617,18617,,,1834041,[],CHEMBL873788,Antibacterial activity against Streptococcus suis BB1009 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18618,18618,,,1834042,[],CHEMBL873789,Antibacterial activity against Streptococcus suis BB1010 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18619,18619,,,1834043,[],CHEMBL873790,Antibacterial activity against Streptococcus suis BB1011 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18620,18620,,,1834044,[],CHEMBL873791,Antibacterial activity against Streptococcus suis BB1012 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18621,18621,,,1834045,[],CHEMBL873792,Antibacterial activity against Streptococcus suis BB1013 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18622,18622,,,1834046,[],CHEMBL873793,Antibacterial activity against Streptococcus suis BB1014 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18623,18623,,,1834047,[],CHEMBL873794,Antibacterial activity against Streptococcus suis BB1015 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18624,18624,,,1834048,[],CHEMBL873795,Antibacterial activity against Streptococcus suis BB1016 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18625,18625,,,1834049,[],CHEMBL873796,Antibacterial activity against Streptococcus suis BB1017 isolate in presence of 10 ug/ml reserpine after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625836,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
18626,18626,,,1834142,[],CHEMBL908151,Antimicrobial activity against Streptococcus pneumoniae R6 in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
18627,18627,,,1834143,[],CHEMBL908152,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18628,18628,,,1834144,[],CHEMBL909796,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18629,18629,,,1834145,[],CHEMBL909797,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18630,18630,,,1834146,[],CHEMBL909798,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18631,18631,,,1834147,[],CHEMBL909799,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18632,18632,,,1834148,[],CHEMBL909800,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
18633,18633,,,1834149,[],CHEMBL909801,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18634,18634,,,1834150,[],CHEMBL909802,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18635,18635,,,1834151,[],CHEMBL909803,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18636,18636,,,1834152,[],CHEMBL909804,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18637,18637,,,1834153,[],CHEMBL909805,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18638,18638,,,1834154,[],CHEMBL909806,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18639,18639,,,1834155,[],CHEMBL909807,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
18640,18640,,,1834156,[],CHEMBL909808,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18641,18641,,,1834157,[],CHEMBL909809,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18642,18642,,,1834158,[],CHEMBL909810,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18643,18643,,,1834159,[],CHEMBL909811,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18644,18644,,,1834160,[],CHEMBL909812,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation in presence of reserpine,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625883,<,1,1,<,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18645,18645,,Active,1834540,[],CHEMBL910814,Bactericidal activity against Escherichia coli DM4100 in the presence of chloramphenicol,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625567,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18646,18646,,Active,1834541,[],CHEMBL910813,Bactericidal activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625567,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18647,18647,,Active,1834542,[],CHEMBL910812,Bactericidal activity against Escherichia coli DM4100 in saline,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,625567,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18648,18648,,,1834551,[],CHEMBL917951,Antimicrobial activity against carbapenem-resistant Klebsiella pneumoniae ZR01 from patient sputum by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142210,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626026,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
18649,18649,,,1834563,[],CHEMBL917952,Antimicrobial activity against Escherichia coli DH5-alpha pYW1 transformants expressing KPC2 gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142210,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626026,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
18650,18650,,,1834575,[],CHEMBL917953,Antimicrobial activity against Escherichia coli DH5-alpha with pYW2 expressing KPC2 and TEM1 gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142210,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626026,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
18651,18651,,,1834587,[],CHEMBL917954,Antimicrobial activity against Escherichia coli DH5-alpha with pGEM-T EASY expressing TEM1 gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142210,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626026,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
18652,18652,,,1834599,[],CHEMBL917955,Antimicrobial activity against Escherichia coli DH5alpha by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142210,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626026,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
18653,18653,,,1835588,[],CHEMBL917049,Antimicrobial activity against Mycobacterium tuberculosis H37Rv in 7H9 broth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626034,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
18654,18654,,,1835591,[],CHEMBL917957,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774A.1 macrophages,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626034,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,4.0
18655,18655,,,1835595,[],CHEMBL917958,Fraction unbound ligand in mouse plasma at 0.01 to 50 mg/litre,A,,,BAO_0000179,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,1,=,,Fu,,,0.33,CHEMBL613589,Mus musculus,Plasma,10090.0,,,Fu,,,,0.33
18656,18656,,,1835608,[],CHEMBL917966,"AUC(0-infinity) in BALB/c mouse at 37.5 to 2400 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,1,=,,AUC,ng.hr.mL-1,,29000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,29.0
18657,18657,,,1835618,[],CHEMBL917959,Antimicrobial activity against Mycobacterium tuberculosis H3Rv on day 7,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,0,=,,log10CFU/ml,,,3.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10CFU/ml,,,,3.0
18658,18658,,Active,1835640,[],CHEMBL917960,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 1,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
18659,18659,,Active,1835648,[],CHEMBL917962,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 14,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
18660,18660,,,1835649,[],CHEMBL917961,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 7,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,0,=,,log10CFU/ml,,,3.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10CFU/ml,,,,3.2
18661,18661,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1835656,[],CHEMBL917963,"Cmax in BALB/c mouse at 37.5 to 2400 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,626034,=,1,1,=,,Cmax,nM,,3621.55,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,1.2
18662,18662,,,1835658,[],CHEMBL917969,"Half life in BALB/c mouse at 37.5 to 2400 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,626034,=,1,1,=,,T1/2,hr,,4.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,4.74
18663,18663,,,1835680,[],CHEMBL919458,"Ratio of fraction AUC in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 100000 mg/kg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,0,=,,RatioAUC/MIC,,,4.0,CHEMBL612558,,ADMET,,,,RatioAUC/MIC,,,,4.0
18664,18664,,,1835689,[],CHEMBL919459,"Ratio of fraction Cmax in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 100000 mg/kg, po",A,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,0,=,,Ratio,,,5.0,CHEMBL612558,,ADMET,,,,Ratio,,,,5.0
18665,18665,,Not Evaluated,1835757,[],CHEMBL917977,Reduction of Mycobacterium tuberculosis H37Rv in orally dosed BALB/c mouse lung,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
18666,18666,,,1835815,[],CHEMBL854042,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18667,18667,,,1835830,[],CHEMBL854043,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18668,18668,,,1835845,[],CHEMBL854044,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18669,18669,,,1835860,[],CHEMBL854045,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18670,18670,,,1835875,[],CHEMBL854046,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18671,18671,,,1835890,[],CHEMBL854047,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18672,18672,,,1835905,[],CHEMBL854048,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
18673,18673,,,1835920,[],CHEMBL854049,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
18674,18674,,,1835935,[],CHEMBL854050,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
18675,18675,,,1835950,[],CHEMBL854051,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18676,18676,,,1835965,[],CHEMBL854052,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
18677,18677,,,1835980,[],CHEMBL854053,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
18678,18678,,,1835995,[],CHEMBL854054,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
18679,18679,,,1836010,[],CHEMBL854140,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
18680,18680,,,1836025,[],CHEMBL854141,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18681,18681,,,1836040,[],CHEMBL855232,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18682,18682,,,1836055,[],CHEMBL855233,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
18683,18683,,,1836070,[],CHEMBL855234,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
18684,18684,,,1836085,[],CHEMBL855231,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18685,18685,,,1836100,[],CHEMBL855786,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
18686,18686,,,1836115,[],CHEMBL855787,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
18687,18687,,,1836130,[],CHEMBL855788,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18688,18688,,,1836145,[],CHEMBL855789,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
18689,18689,,,1836160,[],CHEMBL855790,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
18690,18690,,,1836175,[],CHEMBL855791,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
18691,18691,,,1836190,[],CHEMBL855792,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18692,18692,,,1836205,[],CHEMBL855793,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
18693,18693,,,1836220,[],CHEMBL855794,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
18694,18694,,,1836235,[],CHEMBL855795,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
18695,18695,,,1836250,[],CHEMBL855796,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18696,18696,,,1836265,[],CHEMBL855797,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
18697,18697,,,1836280,[],CHEMBL855798,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
18698,18698,,,1836295,[],CHEMBL855799,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
18699,18699,,,1836310,[],CHEMBL854744,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18700,18700,,,1836324,[],CHEMBL854745,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18701,18701,,,1836339,[],CHEMBL854746,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18702,18702,,,1836354,[],CHEMBL854747,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
18703,18703,,,1836369,[],CHEMBL854748,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
18704,18704,,,1836384,[],CHEMBL854749,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18705,18705,,,1836399,[],CHEMBL854750,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18706,18706,,,1836414,[],CHEMBL855813,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
18707,18707,,,1836429,[],CHEMBL855814,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18708,18708,,,1836444,[],CHEMBL855815,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
18709,18709,,,1836459,[],CHEMBL855816,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625581,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
18710,18710,,,1836911,[],CHEMBL919460,"Drug level in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 100000 mg/kg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,626034,=,1,0,=,,T>MIC,%,,10.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T>MIC,%,UO_0000187,,10.0
18711,18711,,,1836912,[],CHEMBL919461,"Toxicity in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 100000 mg/kg, po",T,,,BAO_0002117,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,626034,=,1,1,=,,LD50,mg.kg-1,,2000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,2000.0
18712,18712,,,1847306,[],CHEMBL918716,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA at 5 ug by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142063,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,631992,=,1,1,=,,IZ,mm,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,26.0
18713,18713,,,1847328,[],CHEMBL918737,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,<=,1,1,<=,,MIC,ug.mL-1,,0.0313,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0313
18714,18714,,,1847329,[],CHEMBL918737,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.25
18715,18715,,,1847330,[],CHEMBL918737,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,8.0
18716,18716,,,1847340,[],CHEMBL918738,Antibacterial activity against ceftazidime-resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0625
18717,18717,,,1847341,[],CHEMBL918738,Antibacterial activity against ceftazidime-resistant Pseudomonas aeruginosa,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,2.0
18718,18718,,,1847342,[],CHEMBL918738,Antibacterial activity against ceftazidime-resistant Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
18719,18719,,,1847352,[],CHEMBL918739,Antibacterial activity against imipenem-resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0625
18720,18720,,,1847353,[],CHEMBL918739,Antibacterial activity against imipenem-resistant Pseudomonas aeruginosa,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
18721,18721,,,1847354,[],CHEMBL918739,Antibacterial activity against imipenem-resistant Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,8.0
18722,18722,,,1847364,[],CHEMBL918740,Antibacterial activity against ciprofloxacin-resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
18723,18723,,,1847365,[],CHEMBL918740,Antibacterial activity against ciprofloxacin-resistant Pseudomonas aeruginosa,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,8.0
18724,18724,,,1847366,[],CHEMBL918740,Antibacterial activity against ciprofloxacin-resistant Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
18725,18725,,,1847445,[],CHEMBL917269,Antibacterial activity against Pseudomonas aeruginosa KG2212 producing MexAB-OprM efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18726,18726,,,1847448,[],CHEMBL917270,Antibacterial activity against Pseudomonas aeruginosa KG3056 producing MexCD-OprJ efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
18727,18727,,,1847451,[],CHEMBL917271,Antibacterial activity against Pseudomonas aeruginosa KG4545 producing MexXY efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18728,18728,,,1847454,[],CHEMBL918174,Antibacterial activity against Pseudomonas aeruginosa KG4001 producing MexEF-OprN efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
18729,18729,,,1847457,[],CHEMBL918175,Antibacterial activity against Pseudomonas aeruginosa PAO1,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
18730,18730,,,1847460,[],CHEMBL918176,Antibacterial activity against Pseudomonas aeruginosa PAO4222,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142065,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632002,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
18731,18731,,,1847762,[],CHEMBL920566,Antimicrobial susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patient assessed as percent susceptible isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142070,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,632036,=,1,0,=,,Activity,%,,5.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,Activity,%,UO_0000187,,5.0
18732,18732,,,1847771,[],CHEMBL920568,Antimicrobial activity against Pseudomonas aeruginosa PA0905,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142071,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632051,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
18733,18733,,,1848439,[],CHEMBL918749,Antibacterial activity against Pseudomonas aeruginosa PAO1 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18734,18734,,,1848443,[],CHEMBL919677,Antibacterial activity against Pseudomonas aeruginosa FE10 with inactivated nuoG gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18735,18735,,,1848447,[],CHEMBL919678,Antibacterial activity against Pseudomonas aeruginosa FE49 with inactivated galU gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18736,18736,,,1848451,[],CHEMBL919679,Antibacterial activity against Pseudomonas aeruginosa FE53 with inactivated mexZ gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18737,18737,,,1848455,[],CHEMBL919680,Antibacterial activity against Pseudomonas aeruginosa FE57 with inactivated rplY gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18738,18738,,,1848459,[],CHEMBL919681,Antibacterial activity against Pseudomonas aeruginosa FE57 containing inactivated rplY gene with pARAL25 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18739,18739,,,1848463,[],CHEMBL919682,Antibacterial activity against Pseudomonas aeruginosa FE10U with inactivated nuoG and galU genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18740,18740,,,1848467,[],CHEMBL919683,Antibacterial activity against Pseudomonas aeruginosa FE53U with inactivated mexZ and galU genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18741,18741,,,1848471,[],CHEMBL919684,Antibacterial activity against Pseudomonas aeruginosa FE57U with inactivated rplY and galU genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18742,18742,,,1848475,[],CHEMBL919685,Antibacterial activity against Pseudomonas aeruginosa FE53G with inactivated mexZ and nuoG genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18743,18743,,,1848479,[],CHEMBL919686,Antibacterial activity against Pseudomonas aeruginosa FE57G with inactivated rplY and nuoG genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18744,18744,,,1848483,[],CHEMBL919687,Antibacterial activity against Pseudomonas aeruginosa FE57Z with inactivated rplY and mexZ genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18745,18745,,,1848487,[],CHEMBL919143,"Antibacterial activity against Pseudomonas aeruginosa FE53GU with inactivated mexZ, nuoG and galU genes by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18746,18746,,,1848491,[],CHEMBL919144,"Antibacterial activity against Pseudomonas aeruginosa FE57GU with inactivated rplY, nuoG and galU genes by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
18747,18747,,,1848495,[],CHEMBL919145,"Antibacterial activity against Pseudomonas aeruginosa FE57UZ with inactivated rplY, galU and mexZ genes by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18748,18748,,,1848499,[],CHEMBL919146,"Antibacterial activity against Pseudomonas aeruginosa FE57GZ with inactivated rplY, nuoG and mexZ genes by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18749,18749,,,1848503,[],CHEMBL919147,"Antibacterial activity against Pseudomonas aeruginosa FE57GUZ with inactivated rplY, nuoG, galU and mexZ genes by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18750,18750,,,1848507,[],CHEMBL919148,Antibacterial activity against Pseudomonas aeruginosa KJ7106 with inactivated PA5471 gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18751,18751,,,1848511,[],CHEMBL919149,Antibacterial activity against Pseudomonas aeruginosa FE60 containing inactivated mexXY gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18752,18752,,,1848515,[],CHEMBL919150,Antibacterial activity against Pseudomonas aeruginosa FE63 containing inactivated rplY and PA5471 genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18753,18753,,,1848519,[],CHEMBL919151,Antibacterial activity against Pseudomonas aeruginosa FE64 containing inactivated rplY and mexXY genes by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142088,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632121,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
18754,18754,,,1848610,[],CHEMBL919160,Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632133,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
18755,18755,,,1848621,[],CHEMBL919161,Antibacterial activity against Escherichia coli AG102MB after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632133,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0625
18756,18756,,,1848632,[],CHEMBL919162,Antibacterial activity against Escherichia coli HNCE4 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632133,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0625
18757,18757,,Not Active,1848653,[],CHEMBL919163,Effect on modulation in uptake of [3H]progesterone in Escherichia coli AG102 with marR1 mutation,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,632133,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18758,18758,,Active,1848655,[],CHEMBL919171,Effect on modulation in uptake of [3H]progesterone in Escherichia coli AG102MB,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,632133,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
18759,18759,,Active,1848656,[],CHEMBL920580,Effect on modulation in uptake of [3H]progesterone in Escherichia coli HNCE4,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142090,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,632133,,1,0,,,AD50,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,AD50,,,,
18760,18760,,,1848817,[],CHEMBL914565,Increase in ROS levels in Escherichia coli K12 MG1655 assessed as ratio of ROS with antibiotic to ROS without antibiotic,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1142094,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,632161,=,1,0,=,,Ratio,,,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.1
18761,18761,,,1850136,[],CHEMBL920752,Antimicrobial susceptibility against Haemophilus influenzae A isolate with GyrA Glu83Cys and AcrR 97stop codon mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.01
18762,18762,,,1850137,[],CHEMBL920753,"Antimicrobial susceptibility against Haemophilus influenzae A1 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
18763,18763,,,1850138,[],CHEMBL920754,"Antimicrobial susceptibility against Haemophilus influenzae A2 with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
18764,18764,,,1850139,[],CHEMBL920755,"Antimicrobial susceptibility against Haemophilus influenzae A3 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
18765,18765,,,1850140,[],CHEMBL920756,"Antimicrobial susceptibility against Haemophilus influenzae A4 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
18766,18766,,,1850141,[],CHEMBL920196,Antimicrobial susceptibility against Haemophilus influenzae B isolate with AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
18767,18767,,,1850142,[],CHEMBL920197,Antimicrobial susceptibility against Haemophilus influenzae B1 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.12
18768,18768,,,1850143,[],CHEMBL920198,Antimicrobial susceptibility against Haemophilus influenzae B2 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
18769,18769,,,1850144,[],CHEMBL920199,Antimicrobial susceptibility against Haemophilus influenzae C isolate with AcrR Leu31His and Arg34Glu mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.01
18770,18770,,,1850145,[],CHEMBL920200,"Antimicrobial susceptibility against Haemophilus influenzae C1 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.12
18771,18771,,,1850146,[],CHEMBL920201,"Antimicrobial susceptibility against Haemophilus influenzae C2 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
18772,18772,,,1850147,[],CHEMBL920207,"Antimicrobial susceptibility against Haemophilus influenzae D4 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,16.0
18773,18773,,,1850148,[],CHEMBL920202,"Antimicrobial susceptibility against Haemophilus influenzae C3 isolate with GyrA Asp88Asn, ParC Ser84Ile, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
18774,18774,,,1850149,[],CHEMBL920203,"Antimicrobial susceptibility against Haemophilus influenzae D isolate with AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.01
18775,18775,,,1850150,[],CHEMBL920204,"Antimicrobial susceptibility against Haemophilus influenzae D1 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
18776,18776,,,1850151,[],CHEMBL920205,"Antimicrobial susceptibility against Haemophilus influenzae D2 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
18777,18777,,,1850152,[],CHEMBL920206,"Antimicrobial susceptibility against Haemophilus influenzae D3 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634940,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
18778,18778,,Not Determined,1850687,[],CHEMBL914061,Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by Alamar blue assay,F,,,BAO_0002144,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC90,,,,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,,IC90,,,,
18779,18779,,Not Determined,1850688,[],CHEMBL914061,Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by Alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,,IC50,,,,
18780,18780,,Not Determined,1850696,[],CHEMBL914063,Cytotoxicity against Vero cells by neutral red assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
18781,18781,,Not Determined,1850699,[],CHEMBL914065,Cytotoxicity against LLC-PK1 cells by neutral red assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,,IC50,,,,
18782,18782,,,1850705,[],CHEMBL914067,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,633656,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.1
18783,18783,,Not Determined,1850709,[],CHEMBL914068,Antifungal activity against Candida albicans,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IC50,,,,
18784,18784,,Not Determined,1850719,[],CHEMBL914071,Antifungal activity against Cryptococcus neoformans,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,IC50,,,,
18785,18785,,Not Determined,1850728,[],CHEMBL914073,Antimalarial activity against Plasmodium falciparum D6,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,,,,
18786,18786,,Not Determined,1850745,[],CHEMBL914074,Antimalarial activity against Plasmodium falciparum W2,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,IC50,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,,,,
18787,18787,,Not Active,1850811,[],CHEMBL915560,Antimicrobial activity against Mycobacterium intracellular,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,Activity,,,,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,Activity,,,,
18788,18788,,Not Active,1850828,[],CHEMBL915561,Antifungal activity against Aspergillus fumigatus,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144532,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,633656,,1,0,,,Activity,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,Activity,,,,
18789,18789,,,1855257,[],CHEMBL916520,Antibacterial activity against Mycobacterium intracellular ATCC 23068,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145530,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634612,=,1,1,=,,IC50,ug.mL-1,,0.35,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,ug ml-1,UO_0000274,,0.35
18790,18790,,Not Determined,1855388,[],CHEMBL916526,Cytotoxicity against Vero cells,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145530,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634612,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
18791,18791,,,1858586,[],CHEMBL915989,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 to 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,1,=,,IC50,ug.mL-1,,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.09
18792,18792,,,1858587,[],CHEMBL915989,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.31
18793,18793,,,1858588,[],CHEMBL915989,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 to 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,0,=,,MBC,ug ml-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.5
18794,18794,,,1858589,[],CHEMBL915990,Antibacterial activity against Mycobacterium intracellular ATCC 23068 after 68 to 72 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,1,=,,IC50,ug.mL-1,,0.3,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,ug ml-1,UO_0000274,,0.3
18795,18795,,,1858590,[],CHEMBL915990,Antibacterial activity against Mycobacterium intracellular ATCC 23068 after 68 to 72 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,1,=,,MIC,ug.mL-1,,0.63,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,0.63
18796,18796,,,1858591,[],CHEMBL915990,Antibacterial activity against Mycobacterium intracellular ATCC 23068 after 68 to 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144547,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634084,=,1,0,=,,MBC,ug ml-1,,2.5,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MBC,ug ml-1,UO_0000274,,2.5
18797,18797,,,1859274,[],CHEMBL918819,Antimicrobial activity against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18798,18798,,,1859276,[],CHEMBL918820,Antimicrobial activity against Staphylococcus aureus ATCC 105487,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18799,18799,,,1859277,[],CHEMBL918821,Antimicrobial activity against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
18800,18800,,,1859278,[],CHEMBL918822,Antimicrobial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.25
18801,18801,,,1859279,[],CHEMBL918823,Antimicrobial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
18802,18802,,,1859280,[],CHEMBL918824,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27753,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
18803,18803,,,1859294,[],CHEMBL918825,Antimicrobial activity against Staphylococcus aureus 52,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
18804,18804,,,1859296,[],CHEMBL918826,Antimicrobial activity against Staphylococcus aureus 85,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18805,18805,,,1859309,[],CHEMBL918827,Antimicrobial activity against Staphylococcus aureus 87,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18806,18806,,,1859310,[],CHEMBL918828,Antimicrobial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
18807,18807,,,1859311,[],CHEMBL918829,Antimicrobial activity against Mycobacterium tuberculosis H160,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
18808,18808,,,1859312,[],CHEMBL918830,Antimicrobial activity against Mycobacterium tuberculosis H190,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144555,Bioorg Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634195,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
18809,18809,,,1865902,[],CHEMBL917510,Antibacterial efficacy against methicillin-susceptible Staphylococcus aureus UC76 infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,=,1,0,=,,PD50,mg kg-1,,9.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,9.1
18810,18810,,,1865904,[],CHEMBL917510,Antibacterial efficacy against methicillin-susceptible Staphylococcus aureus UC76 infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
18811,18811,,Not Determined,1865912,[],CHEMBL917514,Antibacterial efficacy against Enterococcus faecalis MGH2 infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,PD50,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PD50,,,,
18812,18812,,,1865913,[],CHEMBL917513,Antibacterial efficacy against Streptococcus pyogenes C203 infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
18813,18813,,,1865914,[],CHEMBL917513,Antibacterial efficacy against Streptococcus pyogenes C203 infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,100.0
18814,18814,,,1865930,[],CHEMBL917511,Antibacterial efficacy against methicillin-resistant Staphylococcus aureus SA1417 infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,=,1,0,=,,PD50,mg kg-1,,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,18.0
18815,18815,,,1865931,[],CHEMBL917511,Antibacterial efficacy against methicillin-resistant Staphylococcus aureus SA1417 infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
18816,18816,,,1865932,[],CHEMBL917509,Antibacterial efficacy against ciprofloxacin and methicillin-resistant Staphylococcus aureus SA2017 infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,100.0
18817,18817,,,1865934,[],CHEMBL917509,Antibacterial efficacy against ciprofloxacin and methicillin-resistant Staphylococcus aureus SA2017 infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18818,18818,,,1865937,[],CHEMBL917512,Antibacterial efficacy against Streptococcus pneumoniae SVI infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
18819,18819,,,1865939,[],CHEMBL917512,Antibacterial efficacy against Streptococcus pneumoniae SVI infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
18820,18820,,,1865943,[],CHEMBL917514,Antibacterial efficacy against Enterococcus faecalis MGH2 infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
18821,18821,,Not Determined,1865945,[],CHEMBL917515,Antibacterial efficacy against Escherichia coli Vogel infected orally dosed CD1 mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,PD50,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,,,,
18822,18822,,,1865947,[],CHEMBL917515,Antibacterial efficacy against Escherichia coli Vogel infected orally dosed CD1 mouse model,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634910,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
18823,18823,,,1866148,[],CHEMBL916555,Antimicrobial activity against Escherichia coli qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634768,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
18824,18824,,,1866163,[],CHEMBL916556,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 transconjugant with qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634768,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
18825,18825,,,1866178,[],CHEMBL916557,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634768,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.047
18826,18826,,,1866185,[],CHEMBL915946,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,632433,=,1,1,=,,IZ,mm,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,19.0
18827,18827,,,1866186,[],CHEMBL915946,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632433,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
18828,18828,,,1866187,[],CHEMBL915947,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,632433,=,1,1,=,,IZ,mm,,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,18.0
18829,18829,,,1866188,[],CHEMBL915947,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632433,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.5
18830,18830,,,1866189,[],CHEMBL915948,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,632433,=,1,1,=,,IZ,mm,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,25.0
18831,18831,,,1866190,[],CHEMBL915948,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632433,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.25
18832,18832,,,1866191,[],CHEMBL915949,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,632433,=,1,1,=,,IZ,mm,,20.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,20.0
18833,18833,,,1866192,[],CHEMBL915949,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632433,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.25
18834,18834,,,1866193,[],CHEMBL915950,Antibacterial activity against Streptococcus pyogenes after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,632433,=,1,1,=,,IZ,mm,,20.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,20.0
18835,18835,,,1866194,[],CHEMBL915950,Antibacterial activity against Streptococcus pyogenes after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1144479,Eur J Med Chem,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632433,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,12.5
18836,18836,,,1866399,[],CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634690,=,1,1,=,,MIC,nM,,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.5
18837,18837,,,1866428,[],CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634690,<=,1,1,<=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
18838,18838,,,1866457,[],CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634690,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
18839,18839,,,1866486,[],CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634690,=,1,1,=,,MIC,nM,,33000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,33.0
18840,18840,,,1866514,[],CHEMBL916962,Antibacterial activity against susceptible Campylobacter jejuni isolates by disk diffusion test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634917,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,0.06
18841,18841,,,1866515,[],CHEMBL916962,Antibacterial activity against susceptible Campylobacter jejuni isolates by disk diffusion test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,634917,=,1,1,=,,IZ,mm,,21.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,IZ,mm,UO_0000016,,21.0
18842,18842,,,1866516,[],CHEMBL916966,Antimicrobial activity against ciprofloxacin-resistant Campylobacter jejuni isolates by disk diffusion test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634917,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,4.0
18843,18843,,,1866517,[],CHEMBL916966,Antimicrobial activity against ciprofloxacin-resistant Campylobacter jejuni isolates by disk diffusion test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,634917,=,1,1,=,,IZ,mm,,6.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,IZ,mm,UO_0000016,,6.0
18844,18844,,,1866525,[],CHEMBL914140,Antimicrobial activity against wild type Pseudomonas aeruginosa PAO1 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634888,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/ml,UO_0000274,,0.125
18845,18845,,,1866526,[],CHEMBL914140,Antimicrobial activity against wild type Pseudomonas aeruginosa PAO1 after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634888,=,1,0,=,,MBC,mg/ml,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,mg/ml,,,0.5
18846,18846,,,1866531,[],CHEMBL915071,Antimicrobial activity against Pseudomonas aeruginosa PAO1 with rpoN mutation after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634888,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/ml,UO_0000274,,0.25
18847,18847,,,1866532,[],CHEMBL915071,Antimicrobial activity against Pseudomonas aeruginosa PAO1 with rpoN mutation after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634888,=,1,0,=,,MBC,mg/ml,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,mg/ml,,,2.0
18848,18848,,,1866537,[],CHEMBL915072,Antimicrobial activity against Pseudomonas aeruginosa PAO1 with pvdS mutation after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634888,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/ml,UO_0000274,,0.125
18849,18849,,,1866538,[],CHEMBL915072,Antimicrobial activity against Pseudomonas aeruginosa PAO1 with pvdS mutation after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147102,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634888,=,1,0,=,,MBC,mg/ml,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,mg/ml,,,0.25
18850,18850,,,1866543,[],CHEMBL916967,Antimicrobial activity against ciprofloxacin-resistant Campylobacter jejuni isolate by agar dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634917,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,4.0
18851,18851,,,1866545,[],CHEMBL916964,Antibacterial activity against susceptible Campylobacter jejuni isolates by agar dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147108,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634917,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,0.06
18852,18852,,,1866751,[],CHEMBL916027,Susceptibility of qnr positive Enterobacter cloacae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634789,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.13
18853,18853,,,1866752,[],CHEMBL916027,Susceptibility of qnr positive Enterobacter cloacae,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634789,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,16.0
18854,18854,,,1866772,[],CHEMBL916028,Susceptibility of qnr positive Enterobacter cloacae assessed as percentage nonsusceptible isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,634789,=,1,0,=,,Activity,%,,43.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,43.0
18855,18855,,,1866784,[],CHEMBL916031,Decrease in susceptibility of qnrS-positive transconjugant streptomycin-resistant Escherichia coli C600,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634789,=,1,0,=,,Activity,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,0.25
18856,18856,,,1866792,[],CHEMBL916032,Decrease in susceptibility of qnrB-positive transconjugant streptomycin-resistant Escherichia coli C600,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634789,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
18857,18857,,,1867236,[],CHEMBL914132,Susceptibility of penicillin-resistant Streptococcus pneumoniae 335 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18858,18858,,,1867241,[],CHEMBL914133,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18859,18859,,,1867248,[],CHEMBL914134,Effect on 0.5 ug/ml sitofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18860,18860,,,1867253,[],CHEMBL914135,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18861,18861,,,1867257,[],CHEMBL915624,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
18862,18862,,,1867262,[],CHEMBL915625,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18863,18863,,,1867267,[],CHEMBL915626,Susceptibility of penicillin-resistant Streptococcus pneumoniae 334 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18864,18864,,,1867271,[],CHEMBL914661,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
18865,18865,,,1867275,[],CHEMBL915629,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
18866,18866,,,1867279,[],CHEMBL915630,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
18867,18867,,,1867283,[],CHEMBL915631,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18868,18868,,,1867287,[],CHEMBL915632,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18869,18869,,,1867292,[],CHEMBL915633,Susceptibility of penicillin-resistant Streptococcus pneumoniae 216 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
18870,18870,,,1867296,[],CHEMBL915634,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18871,18871,,,1867302,[],CHEMBL915635,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18872,18872,,,1867306,[],CHEMBL915636,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
18873,18873,,,1867310,[],CHEMBL915637,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18874,18874,,,1867318,[],CHEMBL915638,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18875,18875,,,1867327,[],CHEMBL915639,Susceptibility of penicillin-resistant Streptococcus pneumoniae 217 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18876,18876,,,1867334,[],CHEMBL915640,Effect on 0.03 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18877,18877,,,1867339,[],CHEMBL915641,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18878,18878,,,1867343,[],CHEMBL915642,Effect on 0.5 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18879,18879,,,1867348,[],CHEMBL915643,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
18880,18880,,,1867355,[],CHEMBL915033,Effect on 8 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
18881,18881,,,1867361,[],CHEMBL915034,Susceptibility of penicillin-resistant Streptococcus pneumoniae 218 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
18882,18882,,,1867371,[],CHEMBL915035,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
18883,18883,,,1867382,[],CHEMBL915036,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
18884,18884,,,1867387,[],CHEMBL914130,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
18885,18885,,,1867391,[],CHEMBL915037,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
18886,18886,,,1867396,[],CHEMBL915038,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
18887,18887,,,1867482,[],CHEMBL914131,Susceptibility of methicillin-sensitive/resistant Staphylococcus aureus single-step mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
18888,18888,,,1867496,[],CHEMBL915039,Susceptibility of vancomycin-resistant Enterococcus species single-step mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634753,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,16.0
18889,18889,,,1867953,[],CHEMBL916974,Antimicrobial activity against Bacillus anthracis Ames,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,635026,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,0.25
18890,18890,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1867956,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL916975,"Cmax in BALB/c mouse at 25 mg/kg, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,635026,=,1,1,=,,Cmax,nM,,19918.52,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,6.6
18891,18891,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1867957,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL916976,"Cmax in BALB/c mouse at 50 mg/kg, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,635026,=,1,1,=,,Cmax,nM,,32292.14,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,10.7
18892,18892,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1867958,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL916977,"Cmax in BALB/c mouse at 100 mg/kg, ip",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,635026,=,1,1,=,,Cmax,nM,,60359.14,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,20.0
18893,18893,,,1867959,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '25.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '25.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '6.0'}]",CHEMBL916978,"AUC (0-6h) in BALB/c mouse at 25 mg/kg, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,=,1,1,=,,AUC,ng.hr.mL-1,,6600.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,6.6
18894,18894,,,1867960,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '6.0'}]",CHEMBL916979,"AUC (0-6h) in BALB/c mouse at 50 mg/kg, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,=,1,1,=,,AUC,ng.hr.mL-1,,14100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,14.1
18895,18895,,,1867961,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '6.0'}]",CHEMBL916980,"AUC (0-6h) in BALB/c mouse at 100 mg/kg, ip",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,=,1,1,=,,AUC,ng.hr.mL-1,,37700.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,37.7
18896,18896,,,1867962,[],CHEMBL916981,"Trough level in BALB/c mouse at 25 mg/kg, ip after 6 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,635026,=,1,0,=,,Cmin,ug ml-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmin,ug ml-1,UO_0000274,,1.0
18897,18897,,,1867963,[],CHEMBL916982,"Trough level in BALB/c mouse at 50 mg/kg, ip after 6 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,635026,=,1,0,=,,Cmin,ug ml-1,,1.83,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmin,ug ml-1,UO_0000274,,1.83
18898,18898,,,1867964,[],CHEMBL916983,"Trough level in BALB/c mouse at 100 mg/kg, ip after 6 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,635026,=,1,0,=,,Cmin,ug ml-1,,1.67,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmin,ug ml-1,UO_0000274,,1.67
18899,18899,,Active,1867976,[],CHEMBL916984,"Survival in BALB/c mouse infected with Bacillus anthracis Ames at 30 mg/kg, ip every 12 hrs for 14 days",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
18900,18900,,Active,1867977,[],CHEMBL916987,"Antimicrobial activity against Bacillus anthracis Ames infected BALB/c mouse blood at 30 mg/kg, ip administered every 12 hrs for 21 days",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
18901,18901,,Active,1867978,[],CHEMBL916988,"Antimicrobial activity against Bacillus anthracis Ames infected BALB/c mouse spleen administered 30 mg/kg, ip administered every 12 hrs for 21 days",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
18902,18902,,,1868256,[],CHEMBL919806,Antibacterial activity against Neisseria gonorrhoeae after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC50,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC50,ug ml-1,UO_0000274,,0.004
18903,18903,,,1868257,[],CHEMBL919806,Antibacterial activity against Neisseria gonorrhoeae after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC90,ug ml-1,UO_0000274,,0.008
18904,18904,,,1868290,[],CHEMBL919811,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18905,18905,,,1868293,[],CHEMBL919277,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
18906,18906,,,1868296,[],CHEMBL919807,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
18907,18907,,,1868299,[],CHEMBL919813,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
18908,18908,,,1868302,[],CHEMBL919817,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
18909,18909,,,1868306,[],CHEMBL919278,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18910,18910,,,1868343,[],CHEMBL919279,Antibacterial activity against Staphylococcus aureus Mu50 at pH 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634863,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
18911,18911,,Not Active,1868345,[],CHEMBL916986,"Antimicrobial activity against Bacillus anthracis Ames infected BALB/c mouse lung administered 30 mg/kg, ip administered every 12 hrs for 21 days",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,635026,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
18912,18912,,,1868347,[],CHEMBL916989,"Survival of Bacillus anthracis Ames infected BALB/c mouse at 30 mg/kg, ip every 12 hrs for 14 days administered 36 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,635026,=,1,0,=,,Survival,%,,80.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,80.0
18913,18913,,,1868348,[],CHEMBL916990,"Survival of Bacillus anthracis Ames infected BALB/c mouse at 30 mg/kg, ip every 12 hrs for 14 days administered 48 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147119,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,635026,=,1,0,=,,Survival,%,,80.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,80.0
18914,18914,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1868351,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL919288,"Cmax in mouse at 20 mg/kg, sc",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634863,=,1,1,=,,Cmax,nM,,10140.33,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,3.36
18915,18915,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1868352,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL919289,"Cmax in mouse at 50 mg/kg, sc",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,634863,=,1,1,=,,Cmax,nM,,23298.63,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,7.72
18916,18916,,Active,1868363,[],CHEMBL917520,Bactericidal activity against Streptococcus pneumoniae SV1 at 0.008 ug/ml by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
18917,18917,,Active,1868364,[],CHEMBL917521,Bactericidal activity against Streptococcus pyogenes C203 at 0.008 ug/ml by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,Activity,,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,,,,
18918,18918,,Active,1868365,[],CHEMBL917522,Bactericidal activity against Streptococcus pneumoniae SV1 at 2 ug/ml by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
18919,18919,,Active,1868366,[],CHEMBL917523,Bactericidal activity against Streptococcus pyogenes C203 at 2 ug/ml by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634910,,1,0,,,Activity,,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,,,,
18920,18920,,,1868367,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL919290,"AUC (0-24 hrs) in mouse at 20 mg/kg, sc",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634863,=,1,1,=,,AUC,ng.hr.mL-1,,5950.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,5.95
18921,18921,,,1868368,[],CHEMBL919292,"Plasma half life in mouse at 20 mg/kg, sc",A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,634863,=,1,1,=,,T1/2,hr,,1.07,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,1.07
18922,18922,,,1868369,[],CHEMBL919294,"Tmax in mouse at 20 mg/kg, sc",A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,634863,=,1,1,=,,Tmax,hr,,0.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.5
18923,18923,,,1868370,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL919291,"AUC (0-24 hrs) in mouse at 50 mg/kg, sc",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634863,=,1,1,=,,AUC,ng.hr.mL-1,,14430.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,14.43
18924,18924,,,1868371,[],CHEMBL919293,"Plasma half life in mouse at 50 mg/kg, sc",A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,634863,=,1,1,=,,T1/2,hr,,1.17,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,1.17
18925,18925,,,1868372,[],CHEMBL919295,"Tmax in mouse at 50 mg/kg, sc",A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,634863,=,1,1,=,,Tmax,hr,,0.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,0.5
18926,18926,,Active,1868732,[],CHEMBL920177,Antimicrobial activity against Pseudomonas aeruginosa P21.21 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18927,18927,,Active,1868743,[],CHEMBL920178,Antimicrobial activity against Pseudomonas aeruginosa 65.18-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18928,18928,,Active,1868752,[],CHEMBL920179,Antimicrobial activity against Pseudomonas aeruginosa 65.18-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18929,18929,,Active,1868761,[],CHEMBL920180,Antimicrobial activity against Pseudomonas aeruginosa 65.18-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18930,18930,,Active,1868771,[],CHEMBL920181,Antimicrobial activity against Pseudomonas aeruginosa 65.18-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18931,18931,,Active,1868781,[],CHEMBL920182,Antimicrobial activity against Pseudomonas aeruginosa P21.23 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18932,18932,,Active,1868792,[],CHEMBL920183,Antimicrobial activity against Pseudomonas aeruginosa IA5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18933,18933,,Active,1868803,[],CHEMBL920184,Antimicrobial activity against Pseudomonas aeruginosa IC7 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18934,18934,,Active,1868814,[],CHEMBL920186,Antimicrobial activity against Pseudomonas aeruginosa 65.33-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18935,18935,,Active,1868824,[],CHEMBL920187,Antimicrobial activity against Pseudomonas aeruginosa 65.33-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18936,18936,,Active,1868833,[],CHEMBL920188,Antimicrobial activity against Pseudomonas aeruginosa 65.33-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18937,18937,,Active,1868841,[],CHEMBL920189,Antimicrobial activity against Pseudomonas aeruginosa 65.33-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18938,18938,,Active,1868850,[],CHEMBL920190,Antimicrobial activity against Pseudomonas aeruginosa 65.36-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18939,18939,,Active,1868859,[],CHEMBL920191,Antimicrobial activity against Pseudomonas aeruginosa 65.36-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18940,18940,,Active,1868869,[],CHEMBL920192,Antimicrobial activity against Pseudomonas aeruginosa 65.36-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18941,18941,,Active,1868917,[],CHEMBL920193,Antimicrobial activity against Pseudomonas aeruginosa 65.36-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18942,18942,,Active,1868928,[],CHEMBL920195,Antimicrobial activity against Pseudomonas aeruginosa 65.38-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18943,18943,,Active,1868938,[],CHEMBL912018,Antimicrobial activity against Pseudomonas aeruginosa 65.38-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18944,18944,,Active,1868947,[],CHEMBL912019,Antimicrobial activity against Pseudomonas aeruginosa 65.38-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18945,18945,,Active,1868960,[],CHEMBL912020,Antimicrobial activity against Pseudomonas aeruginosa 1A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18946,18946,,Active,1868963,[],CHEMBL920194,Antimicrobial activity against Pseudomonas aeruginosa 65.38-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18947,18947,,Active,1869028,[],CHEMBL912021,Antimicrobial activity against Pseudomonas aeruginosa 1B9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18948,18948,,Active,1869120,[],CHEMBL912022,Antimicrobial activity against Pseudomonas aeruginosa 1C9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18949,18949,,Active,1869127,[],CHEMBL913069,Antimicrobial activity against Pseudomonas aeruginosa 2A1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18950,18950,,Active,1869144,[],CHEMBL913070,Antimicrobial activity against Pseudomonas aeruginosa 2C1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18951,18951,,Active,1869147,[],CHEMBL913071,Antimicrobial activity against Pseudomonas aeruginosa 2A2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18952,18952,,Active,1869158,[],CHEMBL913072,Antimicrobial activity against Pseudomonas aeruginosa 2C2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18953,18953,,Active,1869168,[],CHEMBL913073,Antimicrobial activity against Pseudomonas aeruginosa 2A3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18954,18954,,Active,1869179,[],CHEMBL913074,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18955,18955,,Active,1869230,[],CHEMBL913075,Antimicrobial activity against Pseudomonas aeruginosa 2B5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18956,18956,,Active,1869244,[],CHEMBL913076,Antimicrobial activity against Pseudomonas aeruginosa 2A6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18957,18957,,Active,1869256,[],CHEMBL913077,Antimicrobial activity against Pseudomonas aeruginosa 2F6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18958,18958,,Active,1869268,[],CHEMBL913078,Antimicrobial activity against Pseudomonas aeruginosa 2A7 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18959,18959,,Active,1869279,[],CHEMBL913079,Antimicrobial activity against Pseudomonas aeruginosa 2A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18960,18960,,Active,1869282,[],CHEMBL913080,Antimicrobial activity against Pseudomonas aeruginosa 3B1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18961,18961,,Active,1869293,[],CHEMBL913081,Antimicrobial activity against Pseudomonas aeruginosa 65.68-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18962,18962,,Active,1869304,[],CHEMBL913082,Antimicrobial activity against Pseudomonas aeruginosa 65.68-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18963,18963,,Active,1869328,[],CHEMBL913083,Antimicrobial activity against Pseudomonas aeruginosa 65.68-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18964,18964,,Active,1869344,[],CHEMBL913085,Antimicrobial activity against Pseudomonas aeruginosa 65.68-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18965,18965,,Active,1869362,[],CHEMBL913086,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18966,18966,,Active,1869372,[],CHEMBL914688,Antimicrobial activity against Pseudomonas aeruginosa 3D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18967,18967,,Active,1869379,[],CHEMBL914689,Antimicrobial activity against Pseudomonas aeruginosa 3D10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18968,18968,,Active,1869389,[],CHEMBL914690,Antimicrobial activity against Pseudomonas aeruginosa 3E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18969,18969,,Active,1869411,[],CHEMBL914691,Antimicrobial activity against Pseudomonas aeruginosa 5F2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18970,18970,,Active,1869423,[],CHEMBL914692,Antimicrobial activity against Pseudomonas aeruginosa 5F8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18971,18971,,Active,1869429,[],CHEMBL914693,Antimicrobial activity against Pseudomonas aeruginosa 5G3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18972,18972,,Active,1869436,[],CHEMBL913084,Antimicrobial activity against Pseudomonas aeruginosa 5H6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18973,18973,,Active,1869458,[],CHEMBL914694,Antimicrobial activity against Pseudomonas aeruginosa 8A2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18974,18974,,Active,1869464,[],CHEMBL914695,Antimicrobial activity against Pseudomonas aeruginosa 8A12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18975,18975,,Active,1869470,[],CHEMBL914696,Antimicrobial activity against Pseudomonas aeruginosa 8C4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18976,18976,,Active,1869503,[],CHEMBL914697,Antimicrobial activity against Pseudomonas aeruginosa 8B11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18977,18977,,Active,1869509,[],CHEMBL914698,Antimicrobial activity against Pseudomonas aeruginosa 9A1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18978,18978,,Active,1869515,[],CHEMBL914699,Antimicrobial activity against Pseudomonas aeruginosa 9A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18979,18979,,Active,1869521,[],CHEMBL914700,Antimicrobial activity against Pseudomonas aeruginosa 9A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18980,18980,,Active,1869527,[],CHEMBL914701,Antimicrobial activity against Pseudomonas aeruginosa 9A10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18981,18981,,Active,1869560,[],CHEMBL914702,Antimicrobial activity against Pseudomonas aeruginosa 9B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18982,18982,,Active,1869566,[],CHEMBL914703,Antimicrobial activity against Pseudomonas aeruginosa 9B5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18983,18983,,Active,1869572,[],CHEMBL914704,Antimicrobial activity against Pseudomonas aeruginosa 10A6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18984,18984,,Active,1869584,[],CHEMBL914705,Antimicrobial activity against Pseudomonas aeruginosa 10A9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18985,18985,,Active,1869590,[],CHEMBL914706,Antimicrobial activity against Pseudomonas aeruginosa 10B1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18986,18986,,Active,1869596,[],CHEMBL914707,Antimicrobial activity against Pseudomonas aeruginosa 10B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18987,18987,,Active,1869602,[],CHEMBL914708,Antimicrobial activity against Pseudomonas aeruginosa 12A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18988,18988,,Active,1869608,[],CHEMBL914136,Antimicrobial activity against Pseudomonas aeruginosa 12A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18989,18989,,Active,1869619,[],CHEMBL914137,Antimicrobial activity against Pseudomonas aeruginosa 12B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18990,18990,,Active,1869640,[],CHEMBL913065,Antimicrobial activity against Pseudomonas aeruginosa 13D11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18991,18991,,Active,1869646,[],CHEMBL913066,Antimicrobial activity against Pseudomonas aeruginosa 13E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18992,18992,,Not Active,1869652,[],CHEMBL913067,Antimicrobial activity against Pseudomonas aeruginosa 15G2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18993,18993,,Active,1869664,[],CHEMBL914141,Antimicrobial activity against Pseudomonas aeruginosa 15H5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18994,18994,,Active,1869687,[],CHEMBL914143,Antimicrobial activity against Pseudomonas aeruginosa 16D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18995,18995,,Active,1869699,[],CHEMBL914145,Antimicrobial activity against Pseudomonas aeruginosa 19B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18996,18996,,Active,1869706,[],CHEMBL914146,Antimicrobial activity against Pseudomonas aeruginosa 19B6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18997,18997,,Active,1869739,[],CHEMBL914148,Antimicrobial activity against Pseudomonas aeruginosa 19C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18998,18998,,Active,1869746,[],CHEMBL914149,Antimicrobial activity against Pseudomonas aeruginosa 19C7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
18999,18999,,Not Active,1869758,[],CHEMBL914151,Antimicrobial activity against Pseudomonas aeruginosa 19D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,634884,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
